%% This BibTeX bibliography file was created using BibDesk.
%% http://bibdesk.sourceforge.net/


%% Created for Juan Manuel Iglesias Artola at 2014-06-16 01:38:10 -0500 


%% Saved with string encoding Unicode (UTF-8) 



@article{Holmen:1995aa,
	Abstract = {Cationic lipids are an effective means for transfecting nucleic acids into a variety of cell types. Very few of these lipids, however, have been reported to be effective with primary cells. We report on the efficacy of several commercially available cationic lipid reagents to transfect plasmid DNA into primary rat hepatocytes in culture. The reagents tested in this study include TransfectAce, LipofectAmine, Lipofectin, N-[1-(2,3-dioleyloxy)propyl]-n,n,n-trimethylammoniumchloride (DOTMA), (N-[1-(2,3-dioleoyloxy)propyl]-N,N,N-trimethyl-ammonium methylsulfate (DOTAP), and cetyltrimethyl-ammonium bromide/dioleoylphosphatidylethanol-amine (CTAB/DOPE). Electron micrographic (EM) studies indicate that similar size Lipofectin and DOTAP vesicles contain DNA-like material internally and that these vesicles attach to the cell membrane. DOTAP vesicles are multilamellar, appear as clusters, and have a high DNA-to-lipid ratio. Lipofectin vesicles appear to attach to the cell surface as individual vesicles. The EM observations are consistent with current theories on the mechanism of transfection by cationic lipids. While Lipofectin has proven to be effective in transfection studies of primary cells in culture, we have found DOTAP to be a viable alternative. DOTAP yields transfection rates in hepatocytes comparable to DOTMA and Lipofectin, however, at lower concentrations of reagent and at considerably less cost. Optimal conditions for transfecting 5 micrograms of plasmid DNA with DOTAP were achieved by utilizing multilamellar (vortexed) vesicles at a concentration of 15 micrograms DOTAP per 2 ml media in 60-mm plates for 2 h transfection time. In this study, DOTAP has proven to be economical, easy to prepare, and very effective in transfecting DNA into primary rat hepatocytes.},
	Address = {Department of Biological Sciences, Western Michigan University, Kalamazoo 49008, USA.},
	Author = {Holmen, S L and Vanbrocklin, M W and Eversole, R R and Stapleton, S R and Ginsberg, L C},
	Crdt = {1995/05/01 00:00},
	Da = {19950914},
	Date = {1995 May},
	Date-Added = {2014-06-16 06:38:09 +0000},
	Date-Modified = {2014-06-16 06:38:09 +0000},
	Dcom = {19950914},
	Doi = {10.1007/BF02634283},
	Edat = {1995/05/01},
	Gr = {AA06728-06/AA/NIAAA NIH HHS/United States; DK43917-01A1/DK/NIDDK NIH HHS/United States},
	Issn = {1071-2690 (Print); 1071-2690 (Linking)},
	Jid = {9418515},
	Journal = {In Vitro Cell Dev Biol Anim},
	Jt = {In vitro cellular \& developmental biology. Animal},
	Language = {eng},
	Lr = {20071114},
	Mh = {Animals; Cells, Cultured; Fatty Acids, Monounsaturated; Lipids; *Liposomes; Liver/*cytology/*metabolism/ultrastructure; Male; Phosphatidylethanolamines; Plasmids; Quaternary Ammonium Compounds; Rats; Rats, Inbred F344; Time Factors; Transfection/*methods},
	Mhda = {1995/05/01 00:01},
	Month = {May},
	Number = {5},
	Own = {NLM},
	Pages = {347--351},
	Pl = {UNITED STATES},
	Pmid = {7633672},
	Pst = {ppublish},
	Pt = {Comparative Study; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.},
	Rn = {0 (Fatty Acids, Monounsaturated); 0 (Lipids); 0 (Liposomes); 0 (Phosphatidylethanolamines); 0 (Quaternary Ammonium Compounds); 104162-48-3 (N-(1-(2,3-dioleyloxy)propyl)-N,N,N-trimethylammonium); 113669-21-9 (1,2-dioleoyloxy-3-(trimethylammonium)propane); 145310-87-8 (transfectACE); 76391-83-8 (1,2-dielaidoylphosphatidylethanolamine)},
	Sb = {IM},
	Status = {MEDLINE},
	Title = {Efficient lipid-mediated transfection of DNA into primary rat hepatocytes.},
	Volume = {31},
	Year = {1995},
	Bdsk-Url-1 = {http://dx.doi.org/10.1007/BF02634283}}

@article{Washbourne:2002aa,
	Abstract = {To illuminate the function of the thousands of genes that make up the complexity of the nervous system, it is critical to be able to introduce and express DNA in neurons. Over the past two decades, many gene transfer methods have been developed, including viral vectors, liposomes and electroporation. Although the perfect gene transfer technique for every application has not yet been developed, recent technical advances have facilitated the ease of neuronal gene transfer and have increased the accessibility of these techniques to all laboratories. In order to select a transfection method for any particular experiment, the specific advantages and disadvantages of each technique must be considered.},
	Address = {Center for Neuroscience, University of California, Davis, Davis, California 95616, USA. pwash@ucdavis.edu},
	Author = {Washbourne, Philip and McAllister, A Kimberley},
	Crdt = {2002/10/09 04:00},
	Da = {20021007},
	Date = {2002 Oct},
	Date-Added = {2014-06-16 06:38:05 +0000},
	Date-Modified = {2014-06-16 06:38:05 +0000},
	Dcom = {20021129},
	Edat = {2002/10/09 04:00},
	Gr = {R01 EY13584/EY/NEI NIH HHS/United States},
	Issn = {0959-4388 (Print); 0959-4388 (Linking)},
	Jid = {9111376},
	Journal = {Curr Opin Neurobiol},
	Jt = {Current opinion in neurobiology},
	Language = {eng},
	Lr = {20071114},
	Mh = {Animals; *DNA, Recombinant; *Genetic Vectors; Humans; Neurons/*physiology; Transfection/*methods; Viruses},
	Mhda = {2002/11/30 04:00},
	Month = {Oct},
	Number = {5},
	Own = {NLM},
	Pages = {566--573},
	Pii = {S0959438802003653},
	Pl = {England},
	Pmid = {12367637},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review},
	Rf = {75},
	Rn = {0 (DNA, Recombinant)},
	Sb = {IM},
	Status = {MEDLINE},
	Title = {Techniques for gene transfer into neurons.},
	Volume = {12},
	Year = {2002}}

@incollection{Schenborn2000,
	Author = {Schenborn, ElaineT. and Goiffon, Virginia},
	Booktitle = {Transcription Factor Protocols},
	Doi = {10.1385/1-59259-686-X:147},
	Editor = {Tymms, MartinJ.},
	Isbn = {978-0-89603-573-7},
	Language = {English},
	Pages = {147-153},
	Publisher = {Humana Press},
	Series = {Methods in Molecular Biology{\texttrademark}},
	Title = {DEAE-Dextran Transfection of Mammalian Cultured Cells},
	Url = {http://dx.doi.org/10.1385/1-59259-686-X%3A147},
	Volume = {130},
	Year = {2000},
	Bdsk-Url-1 = {http://dx.doi.org/10.1385/1-59259-686-X%3A147},
	Bdsk-Url-2 = {http://dx.doi.org/10.1385/1-59259-686-X:147}}

@article{Woods:2003aa,
	Abstract = {Efficient vector transduction of hematopoietic stem cells is a requirement for successful gene therapy of hematologic disorders. We asked whether human umbilical cord blood CD34(+)CD38(lo) nonobese diabetic/severe combined immunodeficiency (NOD/SCID) repopulating cells (SRCs) could be efficiently transduced using lentiviral vectors, with a particular focus on the average number of vector copies integrating into these primitive progenitor cells. Mouse bone marrow was analyzed by fluorescence-activated cell-sorter scanner and by semiquantitative polymerase chain reaction (PCR) to determine the transduction efficiency into SRCs. Lentiviral vector transduction resulted in an average of 22% (range, 3%-90%) of the human cells expressing green fluorescent protein (GFP), however, multiple vector copies were present in human hematopoietic cells, with an average of 5.6 +/- 3.3 (n = 12) copies per transduced cell. To confirm the ability of lentiviral vectors to integrate multiple vector copies into SRCs, linear amplification mediated (LAM)-PCR was used to analyze the integration site profile of a selected mouse showing low-level engraftment and virtually all human cells expressing GFP. Individually picked granulocyte macrophage colony-forming unit colonies derived from the bone marrow of this mouse were analyzed and shown to have the same 5 vector integrants within each colony. Interestingly, one integration site of the 5 that were sequenced in this mouse was located in a known tumor-suppressor gene, BRCA1. Therefore, these findings demonstrate the ability of lentiviral vectors to transduce multiple copies into a subset of NOD/SCID repopulating cells. While this is efficient in terms of transduction and transgene expression, it may increase the risk of insertional mutagenesis.},
	Address = {Department for Molecular Medicine and Gene Therapy, Institute of Laboratory Medicine, Lund University, Sweden.},
	Author = {Woods, Niels-Bjarne and Muessig, Arne and Schmidt, Manfred and Flygare, Johan and Olsson, Karin and Salmon, Patrick and Trono, Didier and von Kalle, Christof and Karlsson, Stefan},
	Crdt = {2002/10/24 04:00},
	Da = {20030131},
	Date = {2003 Feb 15},
	Date-Added = {2014-06-16 04:43:14 +0000},
	Date-Modified = {2014-06-16 04:43:14 +0000},
	Dcom = {20030313},
	Dep = {20021017},
	Doi = {10.1182/blood-2002-07-2238},
	Edat = {2002/10/24 04:00},
	Issn = {0006-4971 (Print); 0006-4971 (Linking)},
	Jid = {7603509},
	Journal = {Blood},
	Jt = {Blood},
	Language = {eng},
	Lr = {20061115},
	Mh = {ADP-ribosyl Cyclase/analysis; Animals; Antigens, CD/analysis; Antigens, CD34/analysis; Antigens, CD38; Bone Marrow Cells; Colony-Forming Units Assay; Fetal Blood/cytology; Flow Cytometry; Genes, Tumor Suppressor; *Genetic Vectors; Granulocytes; Green Fluorescent Proteins; Humans; Lentivirus/*genetics; Luminescent Proteins/genetics; Macrophages; Membrane Glycoproteins; Mice; Mice, Inbred NOD; Mice, SCID; *Mutagenesis, Insertional; Polymerase Chain Reaction; Stem Cell Transplantation; *Transfection; *Virus Integration},
	Mhda = {2003/03/14 04:00},
	Month = {Feb},
	Number = {4},
	Own = {NLM},
	Pages = {1284--1289},
	Phst = {2002/10/17 {$[$}aheadofprint{$]$}},
	Pii = {2002-07-2238},
	Pl = {United States},
	Pmid = {12393514},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, Non-U.S. Gov't},
	Rn = {0 (Antigens, CD); 0 (Antigens, CD34); 0 (Luminescent Proteins); 0 (Membrane Glycoproteins); 147336-22-9 (Green Fluorescent Proteins); EC 3.2.2.5 (ADP-ribosyl Cyclase); EC 3.2.2.5 (Antigens, CD38); EC 3.2.2.5 (CD38 protein, human); EC 3.2.2.5 (Cd38 protein, mouse)},
	Sb = {AIM; IM},
	Status = {MEDLINE},
	Title = {Lentiviral vector transduction of NOD/SCID repopulating cells results in multiple vector integrations per transduced cell: risk of insertional mutagenesis.},
	Volume = {101},
	Year = {2003},
	Bdsk-Url-1 = {http://dx.doi.org/10.1182/blood-2002-07-2238}}

@article{Hacein-Bey-Abina:2002aa,
	Abstract = {BACKGROUND: X-linked severe combined immunodeficiency due to a mutation in the gene encoding the common gamma (gamma(c)) chain is a lethal condition that can be cured by allogeneic stem-cell transplantation. We investigated whether infusion of autologous hematopoietic stem cells that had been transduced in vitro with the gamma(c) gene can restore the immune system in patients with severe combined immunodeficiency. METHODS: CD34+ bone marrow cells from five boys with X-linked severe combined immunodeficiency were transduced ex vivo with the use of a defective retroviral vector. Integration and expression of the gamma(c) transgene and development of lymphocyte subgroups and their functions were sequentially analyzed over a period of up to 2.5 years after gene transfer. RESULTS: No adverse effects resulted from the procedure. Transduced T cells and natural killer cells appeared in the blood of four of the five patients within four months. The numbers and phenotypes of T cells, the repertoire of T-cell receptors, and the in vitro proliferative responses of T cells to several antigens after immunization were nearly normal up to two years after treatment. Thymopoiesis was documented by the presence of naive T cells and T-cell antigen-receptor episomes and the development of a normal-sized thymus gland. The frequency of transduced B cells was low, but serum immunoglobulin levels and antibody production after immunization were sufficient to avoid the need for intravenous immunoglobulin. Correction of the immunodeficiency eradicated established infections and allowed patients to have a normal life. CONCLUSIONS: Ex vivo gene therapy with gamma(c) can safely correct the immune deficiency of patients with X-linked severe combined immunodeficiency.},
	Address = {Laboratoire INSERM, Hopital Necker Enfants Malades, Paris, France.},
	Author = {Hacein-Bey-Abina, Salima and Le Deist, Francoise and Carlier, Frederique and Bouneaud, Cecile and Hue, Christophe and De Villartay, Jean-Pierre and Thrasher, Adrian J and Wulffraat, Nicolas and Sorensen, Ricardo and Dupuis-Girod, Sophie and Fischer, Alain and Davies, E Graham and Kuis, Wietse and Leiva, Lilly and Cavazzana-Calvo, Marina},
	Cin = {N Engl J Med. 2002 Aug 22;347(8):613-4; author reply 613-4. PMID: 12192024; N Engl J Med. 2002 Apr 18;346(16):1241-3. PMID: 11961154},
	Crdt = {2002/04/19 10:00},
	Da = {20020418},
	Date = {2002 Apr 18},
	Date-Added = {2014-06-15 22:54:47 +0000},
	Date-Modified = {2014-06-15 22:54:47 +0000},
	Dcom = {20020425},
	Doi = {10.1056/NEJMoa012616},
	Edat = {2002/04/19 10:00},
	Issn = {1533-4406 (Electronic); 0028-4793 (Linking)},
	Jid = {0255562},
	Journal = {N Engl J Med},
	Jt = {The New England journal of medicine},
	Language = {eng},
	Lr = {20121115},
	Mh = {Antibodies/blood; Antigens, CD/analysis; Bone Marrow Cells; Genetic Linkage; *Genetic Therapy; Genetic Vectors; Humans; Immunoglobulins/blood; Immunoglobulins, Intravenous; Infant; Killer Cells, Natural/physiology; Lymphocyte Count; Male; Moloney murine leukemia virus/genetics; Receptors, Cytokine/genetics; Severe Combined Immunodeficiency/genetics/immunology/*therapy; T-Lymphocytes/immunology/physiology; Transduction, Genetic; Transgenes; X Chromosome},
	Mhda = {2002/04/26 10:01},
	Month = {Apr},
	Number = {16},
	Own = {NLM},
	Pages = {1185--1193},
	Pii = {346/16/1185},
	Pl = {United States},
	Pmid = {11961146},
	Pst = {ppublish},
	Pt = {Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't},
	Rn = {0 (Antibodies); 0 (Antigens, CD); 0 (Immunoglobulins); 0 (Immunoglobulins, Intravenous); 0 (Receptors, Cytokine)},
	Sb = {AIM; IM},
	Status = {MEDLINE},
	Title = {Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy.},
	Volume = {346},
	Year = {2002},
	Bdsk-Url-1 = {http://dx.doi.org/10.1056/NEJMoa012616}}

@article{Roesler:2002aa,
	Abstract = {HIV-1-derived lentivectors are promising for gene transfer into hematopoietic stem cells but require preclinical in vivo evaluation relevant to specific human diseases. Nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice accept human hematopoietic stem cell grafts, providing a unique opportunity for in vivo evaluation of therapies targeting human hematopoietic diseases. We demonstrate for the first time that hematopoietic stem cells from patients with X-linked chronic granulomatous disease (X-CGD) give rise to X-CGD-phenotype neutrophils in the NOD/SCID model that can be corrected using VSV-G-pseudotyped, 3rd-generation, self-inactivating (SIN) lentivector encoding gp91(phox). We transduced X-CGD patient-mobilized CD34(+) peripheral blood stem cells (CD34(+)PBSCs) with lentivector-gp91(phox) or amphotropic oncoretrovirus MFGS-gp91(phox) and evaluated correction ex vivo and in vivo in NOD/SCID mice. Only lentivector transduced CD34(+)PBSCs under ex vivo conditions nonpermissive for cell division, but both vectors performed best under conditions permissive for proliferation (multiple growth factors). Under the latter conditions, lentivector and MFGS achieved significant ex vivo correction of X-CGD CD34(+)PBSCs (18% and 54% of cells expressing gp91(phox), associated with 53% and 163% of normal superoxide production, respectively). However, lentivector, but not MFGS, achieved significant correction of human X-CGD neutrophils arising in vivo in NOD/SCID mice that underwent transplantation (20% and 2.4%, respectively). Thus, 3rd-generation SIN lentivector-gp91(phox) performs well as assessed in human X-CGD neutrophils differentiating in vivo, and our studies suggest that the NOD/SCID model is generally applicable for in vivo study of therapies evaluated in human blood cells expressing a specific disease phenotype.},
	Address = {Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-1886, USA.},
	Author = {Roesler, Joachim and Brenner, Sebastian and Bukovsky, Anatoly A and Whiting-Theobald, Narda and Dull, Thomas and Kelly, Michael and Civin, Curt I and Malech, Harry L},
	Crdt = {2002/10/24 04:00},
	Da = {20021127},
	Date = {2002 Dec 15},
	Date-Added = {2014-06-15 22:54:44 +0000},
	Date-Modified = {2014-06-15 22:54:44 +0000},
	Dcom = {20030128},
	Dep = {20020801},
	Doi = {10.1182/blood-2001-12-0165},
	Edat = {2002/10/24 04:00},
	Gr = {P01 CA70970/CA/NCI NIH HHS/United States},
	Issn = {0006-4971 (Print); 0006-4971 (Linking)},
	Jid = {7603509},
	Journal = {Blood},
	Jt = {Blood},
	Language = {eng},
	Lr = {20121115},
	Mh = {Animals; Antigens, CD34/analysis; Cell Division; Defective Viruses/*genetics; Genetic Complementation Test; *Genetic Therapy; Genetic Vectors/*therapeutic use; Granulocyte Colony-Stimulating Factor/pharmacology; Granulomatous Disease, Chronic/enzymology/genetics/*therapy; HIV-1/*genetics; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells/enzymology; Humans; K562 Cells; Membrane Glycoproteins/deficiency/*genetics; Mice; Mice, Inbred NOD; Mice, SCID; NADPH Oxidase/*deficiency/genetics; *Peripheral Blood Stem Cell Transplantation; Phosphoproteins/genetics; Retroviridae/genetics; Transplantation, Heterologous; Vesicular stomatitis Indiana virus/physiology; X Chromosome/genetics},
	Mhda = {2003/01/29 04:00},
	Month = {Dec},
	Number = {13},
	Own = {NLM},
	Pages = {4381--4390},
	Phst = {2002/08/01 {$[$}aheadofprint{$]$}},
	Pii = {2001-12-0165},
	Pl = {United States},
	Pmid = {12393624},
	Pst = {ppublish},
	Pt = {Comparative Study; Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.},
	Rn = {0 (Antigens, CD34); 0 (CYBB protein, human); 0 (Membrane Glycoproteins); 0 (Phosphoproteins); 0 (neutrophil cytosol factor 67K); 143011-72-7 (Granulocyte Colony-Stimulating Factor); EC 1.6.3.1 (NADPH Oxidase); EC 1.6.3.1 (neutrophil cytosolic factor 1)},
	Sb = {AIM; IM},
	Status = {MEDLINE},
	Title = {Third-generation, self-inactivating gp91(phox) lentivector corrects the oxidase defect in NOD/SCID mouse-repopulating peripheral blood-mobilized CD34+ cells from patients with X-linked chronic granulomatous disease.},
	Volume = {100},
	Year = {2002},
	Bdsk-Url-1 = {http://dx.doi.org/10.1182/blood-2001-12-0165}}

@article{Pfeifer:2001aa,
	Abstract = {Gene therapy can be broadly defined as the transfer of genetic material to cure a disease or at least to improve the clinical status of a patient. One of the basic concepts of gene therapy is to transform viruses into genetic shuttles, which will deliver the gene of interest into the target cells. Based on the nature of the viral genome, these gene therapy vectors can be divided into RNA and DNA viral vectors. The majority of RNA virus-based vectors have been derived from simple retroviruses like murine leukemia virus. A major shortcoming of these vectors is that they are not able to transduce nondividing cells. This problem may be overcome by the use of novel retroviral vectors derived from lentiviruses, such as human immunodeficiency virus (HIV). The most commonly used DNA virus vectors are based on adenoviruses and adeno-associated viruses. Although the available vector systems are able to deliver genes in vivo into cells, the ideal delivery vehicle has not been found. Thus, the present viral vectors should be used only with great caution in human beings and further progress in vector development is necessary.},
	Address = {The Salk Institute, La Jolla, California 92037, USA. apfeifer{\char64}ems.salk.edu},
	Author = {Pfeifer, A and Verma, I M},
	Crdt = {2001/11/10 10:00},
	Da = {20011109},
	Date = {2001},
	Date-Added = {2014-06-15 22:37:14 +0000},
	Date-Modified = {2014-06-15 22:37:14 +0000},
	Dcom = {20020102},
	Doi = {10.1146/annurev.genom.2.1.177},
	Edat = {2001/11/10 10:00},
	Issn = {1527-8204 (Print); 1527-8204 (Linking)},
	Jid = {100911346},
	Journal = {Annu Rev Genomics Hum Genet},
	Jt = {Annual review of genomics and human genetics},
	Language = {eng},
	Lr = {20121115},
	Mh = {DNA Viruses/genetics; *Genetic Therapy; Genetic Vectors; Humans; RNA Viruses/genetics},
	Mhda = {2002/01/05 10:01},
	Own = {NLM},
	Pages = {177--211},
	Pii = {2/1/177},
	Pl = {United States},
	Pmid = {11701648},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review},
	Rf = {186},
	Sb = {IM},
	Status = {MEDLINE},
	Title = {Gene therapy: promises and problems.},
	Volume = {2},
	Year = {2001},
	Bdsk-Url-1 = {http://dx.doi.org/10.1146/annurev.genom.2.1.177}}

@article{Kim:2010aa,
	Abstract = {Transfection is a powerful analytical tool enabling study of the function of genes and gene products in cells. The transfection methods are broadly classified into three groups; biological, chemical, and physical. These methods have advanced to make it possible to deliver nucleic acids to specific subcellular regions of cells by use of a precisely controlled laser-microscope system. The combination of point-directed transfection and mRNA transfection is a new way of studying the function of genes and gene products. However, each method has its own advantages and disadvantages so the optimum method depends on experimental design and objective.},
	Address = {Department of Pharmacology, University of Pennsylvania Medical School-Pharmacology, 36th and Hamilton Walk, Philadelphia, PA 19104, USA.},
	Author = {Kim, Tae Kyung and Eberwine, James H},
	Crdt = {2010/06/16 06:00},
	Da = {20100729},
	Date = {2010 Aug},
	Date-Added = {2014-06-02 07:26:38 +0000},
	Date-Modified = {2014-06-02 07:26:38 +0000},
	Dcom = {20101109},
	Dep = {20100613},
	Doi = {10.1007/s00216-010-3821-6},
	Edat = {2010/06/16 06:00},
	Issn = {1618-2650 (Electronic)},
	Jid = {101134327},
	Journal = {Anal Bioanal Chem},
	Jt = {Analytical and bioanalytical chemistry},
	Language = {eng},
	Lid = {10.1007/s00216-010-3821-6 {$[$}doi{$]$}},
	Lr = {20131023},
	Mh = {Animals; Cell Line; Genetic Vectors/genetics/metabolism; Humans; Mammals/*genetics/metabolism; Transfection/*methods/*trends},
	Mhda = {2010/11/10 06:00},
	Month = {Aug},
	Number = {8},
	Oid = {NLM: PMC2911531},
	Own = {NLM},
	Pages = {3173--3178},
	Phst = {2010/02/09 {$[$}received{$]$}; 2010/05/03 {$[$}accepted{$]$}; 2010/04/28 {$[$}revised{$]$}; 2010/06/13 {$[$}aheadofprint{$]$}},
	Pl = {Germany},
	Pmc = {PMC2911531},
	Pmid = {20549496},
	Pst = {ppublish},
	Pt = {Evaluation Studies; Journal Article; Review},
	Sb = {IM},
	Status = {MEDLINE},
	Title = {Mammalian cell transfection: the present and the future.},
	Volume = {397},
	Year = {2010},
	Bdsk-Url-1 = {http://dx.doi.org/10.1007/s00216-010-3821-6}}

@article{Fraley:1980aa,
	Abstract = {DNA, isolated from Simian virus 40 (SV40), has been encapsulated in large (0.4-micrometer diameter) unilamellar phospholipid vesicles. The procedure used for liposome preparation encapsulated the SV40 DNA at high efficiency (30 to 50% entrapment) and did not alter the physical or biological properties of the DNA molecules. The biological activity of the liposome-entrapped viral DNA was determined by plaque assays on a permissive monkey cell line. The infectivity of liposome-entrapped SV40 DNA was enhanced at least 100-fold over that of free naked DNA. Importantly, the infectivity of vesicle-entrapped DNA was resistant to DNase digestion, dependent on the amount of DNA encapsulated per vesicle and on the vesicle lipid composition. Liposomes composed of phosphatidylserine were the most efficient for delivery of DNA to cells (1.8 x 10(3) plaque-forming units/micrograms of DNA). Following the incubation of DNA-containing liposomes with cells, their infectivity could be enhanced an additional 10- to 200-fold by exposing the cells to high concentrations of polyethylene glycol or glycerol. Under these conditions the infectivity of liposome-encapsulated SV40 DNA (3 x 10(5) plaque-forming units/microgram) was comparable with values reported using the calcium phosphate method. In addition to providing a sensitive assay for monitoring and optimizing the delivery of vesicle contents to cells, the liposome-mediated delivery of nucleic acids may have potential for increasing the efficiency of DNA delivery to cells and for extending the number of cell types which can be transformed or transfected.},
	Author = {Fraley, R and Subramani, S and Berg, P and Papahadjopoulos, D},
	Crdt = {1980/11/10 00:00},
	Da = {19810129},
	Date = {1980 Nov 10},
	Date-Added = {2014-06-02 07:00:30 +0000},
	Date-Modified = {2014-06-02 07:00:30 +0000},
	Dcom = {19810129},
	Edat = {1980/11/10},
	Gr = {CA 25526-01/CA/NCI NIH HHS/United States},
	Issn = {0021-9258 (Print); 0021-9258 (Linking)},
	Jid = {2985121R},
	Journal = {J Biol Chem},
	Jt = {The Journal of biological chemistry},
	Language = {eng},
	Lr = {20071114},
	Mh = {Animals; Cell Line; Cell Transformation, Viral; DNA, Viral/*metabolism; Haplorhini; Kidney; Kinetics; *Liposomes; Phospholipids; Simian virus 40/*metabolism; Virus Replication},
	Mhda = {1980/11/10 00:01},
	Month = {Nov},
	Number = {21},
	Own = {NLM},
	Pages = {10431--10435},
	Pl = {UNITED STATES},
	Pmid = {6253474},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.},
	Rn = {0 (DNA, Viral); 0 (Liposomes); 0 (Phospholipids)},
	Sb = {IM},
	Status = {MEDLINE},
	Title = {Introduction of liposome-encapsulated SV40 DNA into cells.},
	Volume = {255},
	Year = {1980}}

@article{Wong:1980aa,
	Abstract = {A restriction fragment, 875 bp, which encodes for a beta-lactamase activity, was isolated from the Escherichia coli plasmid pBR322 DNA and entrapped in liposomes. The incubation of the DNA-liposomes with avian, murine, and human cultured cells results in the uptake of the DNA with the efficiency of around 2000 molecules per cell. Extracts of the recipient cells show a beta-lactamase activity as demonstrated by spectroscopic and microbiological methods. These results indicate the expression of a prokaryotic gene in eukaryotic cells.},
	Author = {Wong, T K and Nicolau, C and Hofschneider, P H},
	Crdt = {1980/07/01 00:00},
	Da = {19800923},
	Date = {1980 Jul},
	Date-Added = {2014-06-02 07:00:26 +0000},
	Date-Modified = {2014-06-02 07:00:26 +0000},
	Dcom = {19800923},
	Edat = {1980/07/01},
	Issn = {0378-1119 (Print); 0378-1119 (Linking)},
	Jid = {7706761},
	Journal = {Gene},
	Jt = {Gene},
	Language = {eng},
	Lr = {20061115},
	Mh = {Animals; Cells, Cultured; Chick Embryo; DNA Restriction Enzymes; Escherichia coli/genetics; HeLa Cells/enzymology; Humans; *Liposomes; Plasmids; Spectrophotometry; *Transformation, Genetic; beta-Lactamases/*metabolism},
	Mhda = {1980/07/01 00:01},
	Month = {Jul},
	Number = {2},
	Own = {NLM},
	Pages = {87--94},
	Pl = {NETHERLANDS},
	Pmid = {6248423},
	Pst = {ppublish},
	Pt = {Journal Article},
	Rn = {0 (Liposomes); EC 3.1.21.- (DNA Restriction Enzymes); EC 3.5.2.6 (beta-Lactamases)},
	Sb = {IM},
	Status = {MEDLINE},
	Title = {Appearance of beta-lactamase activity in animal cells upon liposome-mediated gene transfer.},
	Volume = {10},
	Year = {1980}}

@article{Straubinger:1983aa,
	Author = {Straubinger, R M and Papahadjopoulos, D},
	Crdt = {1983/01/01 00:00},
	Da = {19831028},
	Date = {1983},
	Date-Added = {2014-06-02 07:00:23 +0000},
	Date-Modified = {2014-06-02 07:00:23 +0000},
	Dcom = {19831028},
	Edat = {1983/01/01},
	Issn = {0076-6879 (Print); 0076-6879 (Linking)},
	Jid = {0212271},
	Journal = {Methods Enzymol},
	Jt = {Methods in enzymology},
	Language = {eng},
	Lr = {20060501},
	Mh = {Animals; DNA/*genetics; Genetic Engineering/methods; Liposomes/*administration \& dosage; Microchemistry; Phospholipids/isolation \& purification; Plants/genetics; *Plasmids; RNA/*genetics; Rhizobium/genetics; Solvents},
	Mhda = {1983/01/01 00:01},
	Own = {NLM},
	Pages = {512--527},
	Pl = {UNITED STATES},
	Pmid = {6193396},
	Pst = {ppublish},
	Pt = {Journal Article},
	Rn = {0 (Liposomes); 0 (Phospholipids); 0 (Solvents); 63231-63-0 (RNA); 9007-49-2 (DNA)},
	Sb = {IM},
	Status = {MEDLINE},
	Title = {Liposomes as carriers for intracellular delivery of nucleic acids.},
	Volume = {101},
	Year = {1983}}

@article{Fraley:1981aa,
	Abstract = {Delivery of liposome-encapsulated simian virus 40 (SV40) DNA to African green monkey Related to been used as a probe to study liposome--cell interactions and to determine conditions which favor the intracellular delivery of liposome contents to cells. The efficiency of DNA delivery by various liposome preparations (monitored by infectivity assays) was found to be dependent both on the magnitude of vesicle binding to cells and on the resistance of liposomes to cell-induced leakage of contents. Acidic phospholipids were much more effective in both binding and delivery, and phosphatidylserine (PS) was the best in both aspects. The inclusion of 50 mol % cholesterol in liposomes reduces the cell-induced leakage of vesicle contents (2--5-fold) and substantially enhances the delivery of DNA to cells (2--10-fold). Following incubation of cells with negatively charged liposomes containing SV40 DNA, infectivity can be enhanced greatly by brief exposure of the cells to glycerol solutions. In contrast, only slight enhancement by glycerol was observed for SV40 DNA encapsulated in neutral or positively charged liposomes. The results of competition experiments between empty phosphatidylcholine liposomes and DNA-containing PS liposomes also suggest possible differences in the interaction of neutral and negatively charged liposome preparations with cells. Morphological studies indicate that the glycerol treatment stimulates membrane ruffling and vacuolization and suggest that the enhanced uptake of liposomes occurs by an endocytosis-like process. Results obtained with metabolic inhibitors are also consistent with the interpretation that the enhancement of liposome delivery in glycerol-treated cells occurs via an energy-dependent endocytotic pathway. Pretreatment of cells with chloroquine, a drug which alters lysosomal activity, further enhanced infectivity in glycerol-treated cells (4-fold). This observation suggests the involvement of a lysosomal processing step at some point in the expression of liposome-encapsulated DNA and, more importantly, illustrates the possibility of altering cellular mechanism to engineer more efficient delivery by liposomes. Under optimal conditions determined in this study, the efficiency of liposome-mediated SV40 DNA delivery was increased more than 1000-fold over that obtained by simply incubating cells with liposomes. It is also demonstrated that these conditions enhance delivery of other molecules, besides DNA, which are encapsulated in liposomes.},
	Author = {Fraley, R and Straubinger, R M and Rule, G and Springer, E L and Papahadjopoulos, D},
	Crdt = {1981/11/24 00:00},
	Da = {19820313},
	Date = {1981 Nov 24},
	Date-Added = {2014-06-02 07:00:20 +0000},
	Date-Modified = {2014-06-02 07:00:20 +0000},
	Dcom = {19820313},
	Edat = {1981/11/24},
	Gr = {CA 25526/CA/NCI NIH HHS/United States},
	Issn = {0006-2960 (Print); 0006-2960 (Linking)},
	Jid = {0370623},
	Journal = {Biochemistry},
	Jt = {Biochemistry},
	Language = {eng},
	Lr = {20131121},
	Mh = {Animals; Cell Line; *Cell Transformation, Viral; Cercopithecus aethiops; Cholesterol/pharmacology; DNA, Viral/genetics/*metabolism; Glycerol/pharmacology; Kidney; Kinetics; *Liposomes; Microscopy, Electron; Phosphatidylserines; Simian virus 40/*genetics},
	Mhda = {1981/11/24 00:01},
	Month = {Nov},
	Number = {24},
	Own = {NLM},
	Pages = {6978--6987},
	Pl = {UNITED STATES},
	Pmid = {6274382},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.},
	Rn = {0 (DNA, Viral); 0 (Liposomes); 0 (Phosphatidylserines); 97C5T2UQ7J (Cholesterol); PDC6A3C0OX (Glycerol)},
	Sb = {IM},
	Status = {MEDLINE},
	Title = {Liposome-mediated delivery of deoxyribonucleic acid to cells: enhanced efficiency of delivery related to lipid composition and incubation conditions.},
	Volume = {20},
	Year = {1981}}

@article{Straus:1980aa,
	Abstract = {Cell ghosts were formed by hypotonic haemolysis and subsequent isotonic re-sealing of human erythrocytes in the presence of adenovirus type 2 DNA. The ghosts entrapped virus DNA with an efficiency which depended on the salt concentration employed during haemolysis and on the concentration of the DNA itself. The entrapped DNA was largely protected from digestion by deoxyribonuclease I and could be recovered intact by phenol extraction. Erythrocyte ghosts containing 32P-adenovirus type 2 DNA were fused with KB cells during brief treatment with polyethylene glycol (PEG). Following fusion, counts equivalent to an average of 25 molecules of labelled DNA were micro-injected and transported to each KB cell nucleus. Less than 1/4 as many DNA counts were recovered from nuclei when PEG treatment was omitted. A direct immunofluorescent assay demonstrated virus replication in some cells following their fusion with DNA-containing ghosts. The efficiency of transfection was considerably lower than that expected from the large number of successfully micro-injected DNA molecules. This suggests that most of the micro-injected DNA molecules were degraded before a successful infection could be completed.},
	Author = {Straus, S E and Raskas, H J},
	Crdt = {1980/05/01 00:00},
	Da = {19800828},
	Date = {1980 May},
	Date-Added = {2014-06-02 07:00:17 +0000},
	Date-Modified = {2014-06-02 07:00:17 +0000},
	Dcom = {19800828},
	Edat = {1980/05/01},
	Issn = {0022-1317 (Print); 0022-1317 (Linking)},
	Jid = {0077340},
	Journal = {J Gen Virol},
	Jt = {The Journal of general virology},
	Language = {eng},
	Lr = {20061115},
	Mh = {Adenoviruses, Human/*genetics/growth \& development; Cell Fusion; Cell Line; DNA, Viral; Erythrocyte Membrane; Humans; Microinjections; Polyethylene Glycols; *Transfection},
	Mhda = {1980/05/01 00:01},
	Month = {May},
	Number = {1},
	Own = {NLM},
	Pages = {241--245},
	Pl = {ENGLAND},
	Pmid = {7381434},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, U.S. Gov't, P.H.S.},
	Rn = {0 (DNA, Viral); 0 (Polyethylene Glycols)},
	Sb = {IM},
	Status = {MEDLINE},
	Title = {Transfection of KB cells by polyethylene glycol-induced fusion with erythrocyte ghosts containing adenovirus type 2 DNA.},
	Volume = {48},
	Year = {1980}}

@article{Neumann:1982aa,
	Abstract = {Electric impulses (8 kV/cm, 5 microseconds) were found to increase greatly the uptake of DNA into cells. When linear or circular plasmid DNA containing the herpes simplex thymidine kinase (TK) gene is added to a suspension of mouse L cells deficient in the TK gene and the cells are then exposed to electric fields, stable transformants are formed that survive in the HAT selection medium. At 20 degrees C after the application of three successive electric impulses followed by 10 min to allow DNA entry there result 95 (+/- 3) transformants per 10(6) cells and per 1.2 micrograms DNA. Compared with biochemical techniques, the electric field method of gene transfer is very simple, easily applicable, and very efficient. Because the mechanism of DNA transport through cell membranes is not known, a simple physical model for the enhanced DNA penetration into cells in high electric fields is proposed. According to this ' electroporation model' the interaction of the external electric field with the lipid dipoles of a pore configuration induces and stabilizes the permeation sites and thus enhances cross membrane transport.},
	Author = {Neumann, E and Schaefer-Ridder, M and Wang, Y and Hofschneider, P H},
	Crdt = {1982/01/01 00:00},
	Da = {19840727},
	Date = {1982},
	Date-Added = {2014-06-02 07:00:15 +0000},
	Date-Modified = {2014-06-02 07:00:15 +0000},
	Dcom = {19840727},
	Edat = {1982/01/01},
	Issn = {0261-4189 (Print); 0261-4189 (Linking)},
	Jid = {8208664},
	Journal = {EMBO J},
	Jt = {The EMBO journal},
	Language = {eng},
	Lr = {20130925},
	Mh = {Animals; *Cloning, Molecular; Electric Stimulation; *Genes; *Genes, Viral; Kinetics; L Cells (Cell Line)/physiology; Mice; *Plasmids; Simplexvirus/genetics; Thermodynamics; Thymidine Kinase/genetics},
	Mhda = {1982/01/01 00:01},
	Number = {7},
	Oid = {NLM: PMC553119},
	Own = {NLM},
	Pages = {841--845},
	Pl = {ENGLAND},
	Pmc = {PMC553119},
	Pmid = {6329708},
	Pst = {ppublish},
	Pt = {Journal Article},
	Rn = {EC 2.7.1.21 (Thymidine Kinase)},
	Sb = {IM},
	Status = {MEDLINE},
	Title = {Gene transfer into mouse lyoma cells by electroporation in high electric fields.},
	Volume = {1},
	Year = {1982}}

@article{Wigler:1979aa,
	Author = {Wigler, M and Sweet, R and Sim, G K and Wold, B and Pellicer, A and Lacy, E and Maniatis, T and Silverstein, S and Axel, R},
	Crdt = {1979/04/01 00:00},
	Da = {19790925},
	Date = {1979 Apr},
	Date-Added = {2014-06-02 07:00:12 +0000},
	Date-Modified = {2014-06-02 07:00:12 +0000},
	Dcom = {19790925},
	Edat = {1979/04/01},
	Issn = {0092-8674 (Print); 0092-8674 (Linking)},
	Jid = {0413066},
	Journal = {Cell},
	Jt = {Cell},
	Language = {eng},
	Lr = {20091119},
	Mh = {Animals; Base Sequence; Cell Nucleus/physiology; Cells, Cultured/*physiology; Coliphages/genetics; DNA, Viral/genetics; Globins/genetics; Mice; Rabbits; Selection, Genetic; Simplexvirus/genetics; Thymidine Kinase/genetics; *Transformation, Genetic},
	Mhda = {1979/04/01 00:01},
	Month = {Apr},
	Number = {4},
	Own = {NLM},
	Pages = {777--785},
	Pii = {0092-8674(79)90093-X},
	Pl = {UNITED STATES},
	Pmid = {222468},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.},
	Rn = {0 (DNA, Viral); 9004-22-2 (Globins); EC 2.7.1.21 (Thymidine Kinase)},
	Sb = {IM},
	Status = {MEDLINE},
	Title = {Transformation of mammalian cells with genes from procaryotes and eucaryotes.},
	Volume = {16},
	Year = {1979}}

@article{Kawai:1984aa,
	Abstract = {A new procedure for DNA transfection has been developed in a system of chicken embryo fibroblast cells and cloned Rous sarcoma virus DNA by using a polycation reagent as a mediator to adsorb DNA to the cell surface and dimethyl sulfoxide as an agent to facilitate the uptake of adsorbed DNA by the cells. In this new, simple, and convenient polycation-dimethyl sulfoxide transfection, which requires no carrier DNA even with small amounts of DNA, the number of transformed cell foci induced by Rous sarcoma virus DNA was proportional to the dose of the transfecting DNA, and chicken embryo fibroblast cells were successfully transformed by v-src-containing subgenomic DNA as well.},
	Author = {Kawai, S and Nishizawa, M},
	Crdt = {1984/06/01 00:00},
	Da = {19840813},
	Date = {1984 Jun},
	Date-Added = {2014-06-02 07:00:09 +0000},
	Date-Modified = {2014-06-02 07:00:09 +0000},
	Dcom = {19840813},
	Edat = {1984/06/01},
	Issn = {0270-7306 (Print); 0270-7306 (Linking)},
	Jid = {8109087},
	Journal = {Mol Cell Biol},
	Jt = {Molecular and cellular biology},
	Language = {eng},
	Lr = {20131121},
	Mh = {Animals; Avian Sarcoma Viruses/*genetics; Cells, Cultured; Chick Embryo; Cloning, Molecular; DNA, Viral/*genetics; Dimethyl Sulfoxide/*pharmacology; Fibroblasts/physiology; Hexadimethrine Bromide/*pharmacology; Kinetics; Polyamines/*pharmacology; Transfection/*drug effects},
	Mhda = {1984/06/01 00:01},
	Month = {Jun},
	Number = {6},
	Oid = {NLM: PMC368888},
	Own = {NLM},
	Pages = {1172--1174},
	Pl = {UNITED STATES},
	Pmc = {PMC368888},
	Pmid = {6330534},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, Non-U.S. Gov't},
	Rn = {0 (DNA, Viral); 0 (Polyamines); 4C905MSK4W (Hexadimethrine Bromide); YOW8V9698H (Dimethyl Sulfoxide)},
	Sb = {IM},
	Status = {MEDLINE},
	Title = {New procedure for DNA transfection with polycation and dimethyl sulfoxide.},
	Volume = {4},
	Year = {1984}}

@article{McCutchan:1968aa,
	Author = {McCutchan, J H and Pagano, J S},
	Crdt = {1968/08/01 00:00},
	Da = {19681015},
	Date = {1968 Aug},
	Date-Added = {2014-06-02 06:50:58 +0000},
	Date-Modified = {2014-06-02 06:50:58 +0000},
	Dcom = {19681015},
	Edat = {1968/08/01},
	Issn = {0027-8874 (Print); 0027-8874 (Linking)},
	Jid = {7503089},
	Journal = {J Natl Cancer Inst},
	Jt = {Journal of the National Cancer Institute},
	Language = {eng},
	Lr = {20131121},
	Mh = {Animals; Cell Transformation, Neoplastic/drug effects; Culture Techniques; *Cytopathogenic Effect, Viral; *DNA, Viral/analysis; *Dextrans; Haplorhini; *Ion Exchange Resins; Kidney/cytology; Simian virus 40/*pathogenicity},
	Mhda = {1968/08/01 00:01},
	Month = {Aug},
	Number = {2},
	Own = {NLM},
	Pages = {351--357},
	Pl = {UNITED STATES},
	Pmid = {4299537},
	Pst = {ppublish},
	Pt = {Journal Article},
	Rn = {0 (DNA, Viral); 0 (Ion Exchange Resins); K3R6ZDH4DU (Dextrans)},
	Sb = {IM},
	Status = {MEDLINE},
	Title = {Enchancement of the infectivity of simian virus 40 deoxyribonucleic acid with diethylaminoethyl-dextran.},
	Volume = {41},
	Year = {1968}}

@article{Pagano:1967aa,
	Abstract = {The enhancement by diethylaminoethyl-dextran (DEAE-D) of the infectivity of poliovirus ribonucleic acid (RNA) for cell cultures was demonstrated by infective-center as well as by plaque assays, both in nonprimate (L) and primate cell systems (MK, HeLa, LLC-MK(2)). The sensitivity of plaque assays was greatly improved by using a tris (hydroxymethyl)aminomethane-buffered synthetic medium (basal medium Eagle) and freshly confluent cell monolayers. Enhancement of nucleic acid infectivity was directly dependent on the molecular weight of the DEAE-D. Two observations bearing on the action of DEAE-D appeared important: ribonuclease activity was reduced by DEAE-D, and cells pretreated with DEAE-D remained susceptible to infection with RNA in isotonic medium. Appreciable susceptibility of the treated cells persisted for at least 2 hr; the susceptible state could be reversed at will by an application of heparin. Enhancement of nucleic acid infectivity was independent of an effect of DEAE-D on intact virus and agar inhibitors.},
	Author = {Pagano, J S and McCutchan, J H and Vaheri, A},
	Crdt = {1967/10/01 00:00},
	Da = {19700807},
	Date = {1967 Oct},
	Date-Added = {2014-06-02 06:45:13 +0000},
	Date-Modified = {2014-06-02 06:45:13 +0000},
	Dcom = {19700807},
	Edat = {1967/10/01},
	Issn = {0022-538X (Print); 0022-538X (Linking)},
	Jid = {0113724},
	Journal = {J Virol},
	Jt = {Journal of virology},
	Language = {eng},
	Lr = {20131121},
	Mh = {Animals; Cell Line; *Culture Techniques; Dextrans/*pharmacology; Haplorhini; HeLa Cells; Kidney; L Cells (Cell Line); Poliovirus/*pathogenicity; *RNA, Viral},
	Mhda = {1967/10/01 00:01},
	Month = {Oct},
	Number = {5},
	Oid = {NLM: PMC375366},
	Own = {NLM},
	Pages = {891--897},
	Pl = {UNITED STATES},
	Pmc = {PMC375366},
	Pmid = {4316237},
	Pst = {ppublish},
	Pt = {Journal Article},
	Rn = {0 (RNA, Viral); K3R6ZDH4DU (Dextrans)},
	Sb = {IM},
	Status = {MEDLINE},
	Title = {Factors influencing the enhancement of the infectivity of poliovirus ribonucleic acid by diethylaminoethyl-dextran.},
	Volume = {1},
	Year = {1967}}

@article{Cepko:1984aa,
	Author = {Cepko, C L and Roberts, B E and Mulligan, R C},
	Crdt = {1984/07/01 00:00},
	Da = {19840824},
	Date = {1984 Jul},
	Date-Added = {2014-06-02 06:32:46 +0000},
	Date-Modified = {2014-06-02 06:32:46 +0000},
	Dcom = {19840824},
	Edat = {1984/07/01},
	Issn = {0092-8674 (Print); 0092-8674 (Linking)},
	Jid = {0413066},
	Journal = {Cell},
	Jt = {Cell},
	Language = {eng},
	Lr = {20061115},
	Mh = {Cell Transformation, Viral; Cells, Cultured; Gene Amplification; *Genetic Vectors; Moloney murine leukemia virus/genetics; Plasmids; Retroviridae/*genetics},
	Mhda = {1984/07/01 00:01},
	Month = {Jul},
	Number = {3},
	Own = {NLM},
	Pages = {1053--1062},
	Pii = {0092-8674(84)90440-9},
	Pl = {UNITED STATES},
	Pmid = {6331674},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.},
	Sb = {IM},
	Status = {MEDLINE},
	Title = {Construction and applications of a highly transmissible murine retrovirus shuttle vector.},
	Volume = {37},
	Year = {1984}}

@article{Graham:1973aa,
	Author = {Graham, F. L. and van der Eb, A. J.},
	Crdt = {1973/04/01 00:00},
	Da = {19730717},
	Date = {1973 Apr},
	Date-Added = {2014-06-02 06:29:08 +0000},
	Date-Modified = {2014-06-02 06:29:08 +0000},
	Dcom = {19730717},
	Edat = {1973/04/01},
	Issn = {0042-6822 (Print); 0042-6822 (Linking)},
	Jid = {0110674},
	Journal = {Virology},
	Jt = {Virology},
	Language = {eng},
	Lr = {20131121},
	Mh = {*Adenoviridae/growth \& development; Adsorption; Calcium Chloride/pharmacology; Carbon Isotopes; Carcinoma; Cell Line; DNA, Viral/isolation \& purification/*pharmacology; Deoxyribonucleases; Dextrans/pharmacology; Hot Temperature; Humans; Hydrogen-Ion Concentration; Methods; Mouth Neoplasms; Time Factors; Viral Plaque Assay},
	Mhda = {1973/04/01 00:01},
	Month = {Apr},
	Number = {2},
	Own = {NLM},
	Pages = {456--467},
	Pl = {UNITED STATES},
	Pmid = {4705382},
	Pst = {ppublish},
	Pt = {Journal Article},
	Rn = {0 (Carbon Isotopes); 0 (DNA, Viral); EC 3.1.- (Deoxyribonucleases); K3R6ZDH4DU (Dextrans); M4I0D6VV5M (Calcium Chloride)},
	Sb = {IM},
	Status = {MEDLINE},
	Title = {A new technique for the assay of infectivity of human adenovirus 5 DNA.},
	Volume = {52},
	Year = {1973}}

@article{Greenleaf1998,
	Author = {William J. Greenleaf and Mark E. Bolander and Gobinda Sarkar and Mary B. Goldring and James F. Greenleaf},
	Doi = {http://dx.doi.org/10.1016/S0301-5629(98)00003-9},
	Issn = {0301-5629},
	Journal = {Ultrasound in Medicine \& Biology},
	Keywords = {Transfection},
	Number = {4},
	Pages = {587 - 595},
	Title = {Artificial Cavitation Nuclei Significantly Enhance Acoustically Induced Cell Transfection},
	Url = {http://www.sciencedirect.com/science/article/pii/S0301562998000039},
	Volume = {24},
	Year = {1998},
	Bdsk-Url-1 = {http://www.sciencedirect.com/science/article/pii/S0301562998000039},
	Bdsk-Url-2 = {http://dx.doi.org/10.1016/S0301-5629(98)00003-9}}

@article{khaliligene2006,
	Author = {M A Stoff-Khalili and P Dall and D T Curiel},
	Doi = {10.1038/sj.cgt.7700929},
	Journal = {Cancer Gene Therapy},
	Number = {7},
	Pages = {633-647},
	Title = {Gene therapy for carcinoma of the breast},
	Url = {http://dx.doi.org/10.1038/sj.cgt.7700929},
	Volume = {13},
	Year = {2006},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/sj.cgt.7700929}}

@article{Koszarycz2004,
	Author = {Y.J.Koszarycz and G.J. Curran},
	Journal = {Australian eJournal of Theology},
	Keywords = {Animal transgenesis},
	Number = {3},
	Pages = {1-10},
	Title = {Animal Transgenesis and Cloning: Scientific, Religious and Ethical Considerations},
	Url = {http://aejt.com.au/__data/assets/pdf_file/0004/395653/AEJT_3.11_Curran_Koszarycz.pdf},
	Year = {2004},
	Bdsk-Url-1 = {http://aejt.com.au/__data/assets/pdf_file/0004/395653/AEJT_3.11_Curran_Koszarycz.pdf}}

@article{Vile,
	Abstract = {Gene therapy for the treatment of cancer was initiated with high levels of optimism and enthusiasm. Recently, this perception has had to be tempered by the realisation that efficiency and accuracy of gene delivery remain the most significant barriers to its success. So far, there has been a disappointing inability to reach target cells with sufficient efficacy to generate high enough levels of direct killing and this has necessitated the invocation of bystander effects in order for any potential strategy to be convincing. At least in the foreseeable future, clinical advance will come from co-operation with other more established disciplines - such as chemotherapy, radiotherapy and immunotherapy. This is inevitable - and necessary - in order to prove that gene therapy can have efficacy as part of a combinatorial therapy, before hoping to move clinical mountains alone. In addition, there will have to be a thorough understanding of the clinical situations in which gene therapy will be used in order both to understand its own limitations, and to exploit its full potential. This will enable it to find the appropriate clinical niche in which its abilities will be optimally useful. Finally, anyone wishing to practise clinical cancer gene therapy will rapidly have to learn the ways of the free market and be able to juggle commercial necessities with ideological purity. Gene Therapy (2000) 7, 2-8.},
	Author = {Vile,R. G. and Russell,S. J. and Lemoine,N. R.},
	Isbn = {09697128},
	Journal = {Gene therapy},
	Keywords = {Biology--Genetics; Humans; Genetic Vectors; Neovascularization, Pathologic -- prevention & control; Gene Targeting; Immunotherapy -- methods; Genetic Therapy -- methods; Neoplasms -- therapy},
	Language = {English},
	Month = {01},
	Note = {Copyright - Copyright Nature Publishing Group Jan 2000; {\'U}ltima actualizaci{\'o}n - 2013-01-25},
	Number = {1},
	Pages = {2-8},
	Title = {Cancer gene therapy: hard lessons and new courses},
	Url = {http://search.proquest.com/docview/218667829?accountid=45097},
	Volume = {7},
	Year = {2000},
	Bdsk-Url-1 = {http://search.proquest.com/docview/218667829?accountid=45097}}

@article{Chen,
	Abstract = {Dendritic cells (DCs) are the most potent antigen-presenting cells. They play a vital role in the initiation of immune response by presenting antigens to T cells and followed by induction of T-cell response. Reported research in animal studies indicated that vaccine immunity could be a promising alternative therapy for cancer patients. However, broad clinical utility has not been achieved yet, owing to the low transfection efficiency of DCs. Therefore, it is essential to improve the transfection efficiency of DC-based vaccination in immunotherapy. In several studies, DCs were genetically engineered by tumor-associated antigens or by immune molecules such as costimulatory molecules, cytokines, and chemokines. Encouraging results have been achieved in cancer treatment using various animal models. This paper describes the recent progress in gene delivery systems including viral vectors and nonviral carriers for DC-based genetically engineered vaccines. The reverse and three-dimensional transfection systems developed in DCs are also discussed.},
	Author = {Yu-Zhe,Chen and Xing-Lei,Yao and Tabata,Yasuhiko and Nakagawa,Shinsaku and Jian-Qing Gao},
	Isbn = {17402522},
	Journal = {Clinical & Developmental Immunology},
	Keywords = {Medical Sciences--Allergology And Immunology; Antigens, Neoplasm; Cancer Vaccines; Interleukin-2; Cancer; Immune system; Immunology; Cancer therapies; Models, Animal; Animals; Humans; Interleukin-2 -- genetics; Neoplasms -- genetics; Cancer Vaccines -- immunology; Dendritic Cells -- metabolism; Cancer Vaccines -- genetics; Genetic Vectors; Recombination, Genetic; Interleukin-2 -- immunology; Antigens, Neoplasm -- genetics; Antigens, Neoplasm -- immunology; Transfection -- methods; Dendritic Cells -- immunology; Cancer Vaccines -- therapeutic use; Neoplasms -- therapy; Neoplasms -- immunology; Immunotherapy -- methods},
	Language = {English},
	Pages = {565-643},
	Title = {Gene Carriers and Transfection Systems Used in the Recombination of Dendritic Cells for Effective Cancer Immunotherapy},
	Url = {http://search.proquest.com/docview/856979630?accountid=45097},
	Year = {2010},
	Bdsk-Url-1 = {http://search.proquest.com/docview/856979630?accountid=45097}}

@article{Malone01081989,
	Author = {Malone, R W and Felgner, P L and Verma, I M},
	Eprint = {http://www.pnas.org/content/86/16/6077.full.pdf+html},
	Journal = {Proceedings of the National Academy of Sciences},
	Number = {16},
	Pages = {6077-6081},
	Title = {Cationic liposome-mediated RNA transfection},
	Url = {http://www.pnas.org/content/86/16/6077.abstract},
	Volume = {86},
	Year = {1989},
	Bdsk-Url-1 = {http://www.pnas.org/content/86/16/6077.abstract}}

@article{Torchilin18022003,
	Abstract = {Liposomes modified with TAT peptide (TATp-liposomes) showed fast and efficient translocation into the cell cytoplasm with subsequent migration into the perinuclear zone. TATp-liposomes containing a small quantity (10 mol %) of a cationic lipid formed firm noncovalent complexes with DNA. Here, we present results demonstrating both in vitro and in vivo transfection with TATp-liposome--DNA complexes. Mouse NIH/3T3 fibroblasts and rat H9C2 cardiomyocytes were transfected with such complexes in vitro. The transfection with the TATp-liposome-associated pEGFP-N1 plasmid encoding for the green fluorescent protein (GFP) was high, whereas the cytotoxicity was lower than that of commonly used cationic lipid-based gene-delivery systems. Intratumoral injection of TATp-liposome--DNA complexes into the Lewis lung carcinoma tumor of mice also resulted in an expression of GFP in tumor cells. This transfection system should be useful for various protocols of cell treatment in vitro or ex vivo as well as for localized in vivo gene therapy.},
	Author = {Torchilin, Vladimir P. and Levchenko, Tatyana S. and Rammohan, Ram and Volodina, Natalia and Papahadjopoulos-Sternberg, Brigitte and D'Souza, Gerard G. M.},
	Doi = {10.1073/pnas.0435906100},
	Eprint = {http://www.pnas.org/content/100/4/1972.full.pdf+html},
	Journal = {Proceedings of the National Academy of Sciences},
	Number = {4},
	Pages = {1972-1977},
	Title = {Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome--DNA complexes},
	Url = {http://www.pnas.org/content/100/4/1972.abstract},
	Volume = {100},
	Year = {2003},
	Bdsk-Url-1 = {http://www.pnas.org/content/100/4/1972.abstract},
	Bdsk-Url-2 = {http://dx.doi.org/10.1073/pnas.0435906100}}

@article{Mao2001399,
	Author = {Hai-Quan Mao and Krishnendu Roy and Vu L. Troung-Le and Kevin A. Janes and Kevin Y. Lin and Yan Wang and J.Thomas August and Kam W. Leong},
	Doi = {http://dx.doi.org/10.1016/S0168-3659(00)00361-8},
	Issn = {0168-3659},
	Journal = {Journal of Controlled Release},
	Keywords = {Receptor-mediated},
	Number = {3},
	Pages = {399 - 421},
	Title = {Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency},
	Url = {http://www.sciencedirect.com/science/article/pii/S0168365900003618},
	Volume = {70},
	Year = {2001},
	Bdsk-Url-1 = {http://www.sciencedirect.com/science/article/pii/S0168365900003618},
	Bdsk-Url-2 = {http://dx.doi.org/10.1016/S0168-3659(00)00361-8}}

@article{cryanin2004,
	Author = {J F Cryan and C Mombereau},
	Doi = {10.1038/sj.mp.4001457},
	Journal = {Molecular Psychiatry},
	Number = {4},
	Pages = {326-357},
	Title = {In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice},
	Url = {http://dx.doi.org/10.1038/sj.mp.4001457},
	Volume = {9},
	Year = {2004},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/sj.mp.4001457}}

@article{Kawai01061984,
	Abstract = {A new procedure for DNA transfection has been developed in a system of chicken embryo fibroblast cells and cloned Rous sarcoma virus DNA by using a polycation reagent as a mediator to adsorb DNA to the cell surface and dimethyl sulfoxide as an agent to facilitate the uptake of adsorbed DNA by the cells. In this new, simple, and convenient polycation-dimethyl sulfoxide transfection, which requires no carrier DNA even with small amounts of DNA, the number of transformed cell foci induced by Rous sarcoma virus DNA was proportional to the dose of the transfecting DNA, and chicken embryo fibroblast cells were successfully transformed by v-src-containing subgenomic DNA as well.},
	Author = {Kawai, S and Nishizawa, M},
	Doi = {10.1128/MCB.4.6.1172},
	Eprint = {http://mcb.asm.org/content/4/6/1172.full.pdf+html},
	Journal = {Molecular and Cellular Biology},
	Number = {6},
	Pages = {1172-1174},
	Title = {New procedure for DNA transfection with polycation and dimethyl sulfoxide.},
	Url = {http://mcb.asm.org/content/4/6/1172.abstract},
	Volume = {4},
	Year = {1984},
	Bdsk-Url-1 = {http://mcb.asm.org/content/4/6/1172.abstract},
	Bdsk-Url-2 = {http://dx.doi.org/10.1128/MCB.4.6.1172}}

@article{Fox,
	Author = {Fox, M.B. and Esveld, D.C. and Valero, A. and Luttge, R. and Mastwijk, H.C. and Bartels, P.V. and Berg, A. and Boom, R.M.},
	Doi = {10.1007/s00216-006-0327-3},
	Issn = {1618-2642},
	Journal = {Analytical and Bioanalytical Chemistry},
	Keywords = {Electroporation; Microtechnology; Microfluidics; PEF},
	Language = {English},
	Number = {3},
	Pages = {474-485},
	Publisher = {Springer-Verlag},
	Title = {Electroporation of cells in microfluidic devices: a review},
	Url = {http://dx.doi.org/10.1007/s00216-006-0327-3},
	Volume = {385},
	Year = {2006},
	Bdsk-Url-1 = {http://dx.doi.org/10.1007/s00216-006-0327-3}}

@article{Chu11021987,
	Abstract = {A simple and reproducible procedure for the introduction of DNA into mammalian cells by electroporation is described. The parameters involving the cells, the DNA, and the electric field are investigated. The procedure has been applied to a broad range of animal cells. It is capable of transforming more than 1% of the viable cells to the stable expression of a selectable marker.},
	Author = {Chu, Gilbert and Hayakawa, Hiroshi and Berg, Paul},
	Doi = {10.1093/nar/15.3.1311},
	Eprint = {http://nar.oxfordjournals.org/content/15/3/1311.full.pdf+html},
	Journal = {Nucleic Acids Research},
	Number = {3},
	Pages = {1311-1326},
	Title = {Electroporation for the efficient transfection of mammalian cells with DNA},
	Url = {http://nar.oxfordjournals.org/content/15/3/1311.abstract},
	Volume = {15},
	Year = {1987},
	Bdsk-Url-1 = {http://nar.oxfordjournals.org/content/15/3/1311.abstract},
	Bdsk-Url-2 = {http://dx.doi.org/10.1093/nar/15.3.1311}}

@article{Jefferson,
	Author = {Jefferson,Valeria},
	Isbn = {00220892},
	Journal = {Journal of environmental health},
	Keywords = {Physical Fitness And Hygiene; Genetic engineering; Food science; Genetically altered foods; Animals; Technological change; Developing countries--LDCs; Health hazards; Ethics; Hunger; Humans; World Health; Food, Genetically Modified},
	Language = {English},
	Month = {Jul},
	Number = {1},
	Pages = {33-4},
	Title = {The Ethical Dilemma of Genetically Modified Food},
	Url = {http://search.proquest.com/docview/219708991?accountid=45097},
	Volume = {69},
	Year = {2006},
	Bdsk-Url-1 = {http://search.proquest.com/docview/219708991?accountid=45097}}

@article{an1982expression,
	Author = {An, Gynheung and Hidaka, Katsuhiko and Siminovitch, Louis},
	Journal = {Molecular and cellular biology},
	Number = {12},
	Pages = {1628--1632},
	Publisher = {Am Soc Microbiol},
	Title = {Expression of bacterial $\beta$-galactosidase in animal cells},
	Volume = {2},
	Year = {1982}}

@article{PMID:10649786,
	Author = {Keith, MB and Farrell, PJ and Iatrou, K and Behie, LA},
	Issn = {0736-6205},
	Journal = {BioTechniques},
	Month = {January},
	Number = {1},
	Pages = {148---154},
	Title = {Use of flow cytometry to rapidly optimize the transfection of animal cells},
	Url = {http://europepmc.org/abstract/MED/10649786},
	Volume = {28},
	Year = {2000},
	Bdsk-Url-1 = {http://europepmc.org/abstract/MED/10649786}}

@article{Vezzani,
	Abstract = {Gene therapy involves the transfer and expression of a therapeutic gene into a target tissue, and essentially represents an intervention that alters the instruction set of a cell having a dominant effect on the cell phenotype. Gene therapy techniques may provide a realistic therapeutic option for CNS disorders that are difficult to treat with conventional drugs, such as for drug-resistant focal epilepsies. Preclinical studies using a selection of 'therapeutic'genes delivered into the rodent brain showed significant reduction of seizures and inhibition of epileptogenesis, thus establishing the proof-of-principle evidence of the potential applicability of this technology to human epilepsy. The promising potential of gene therapy for the treatment of CNS pathologies still requires further investigation to improve the efficacy and the safety of this approach using clinically relevant experimental models. The recent advances in refining gene therapy tools and in methods of gene delivery make this innovative approach a definite possibility for therapeutic intervention.},
	Author = {Vezzani,Annamaria},
	Isbn = {1473-7175},
	Journal = {Expert Review of Neurotherapeutics},
	Keywords = {Medical Sciences--Psychiatry And Neurology; Gene Transfer Techniques; Humans; Clinical Trials as Topic; Genetic Therapy -- methods; Epilepsy -- therapy},
	Language = {English},
	Month = {12},
	Note = {Copyright - {\copyright} 2007 Future Drugs Ltd; {\'U}ltima actualizaci{\'o}n - 2014-03-31; 1 Fisher RS, Chen DK. New routes for delivery of anti-epileptic medications. Acta Neurol. Taiwan 15, 225-231 (2006); 2 Fraser JF, Luther N, Kaplitt MG. Neurosurgical targeting, delivery, and infusion of gene therapy agents in the brain. In: Gene Therapy Of The Central Nervous System: From Bench To Bedside . Kaplitt MG, During MJ (Eds). Academic Press, NY, USA 67-75 (2006); 3 Shi N, Zhang Y, Zhu C et al. Brain-specific expression of an exogenous gene after iv. administration. Proc. Natl Acad. Sci. USA 98, 12754-12759 (2001); 4 Zhang LX, Li XL, Smith MA, Post RM, Han JS. Lipofectin-facilitated transfer of cholecystokinin gene corrects behavioral abnormalities of rats with audiogenic seizures. Neuroscience 77, 15-22 (1997); 5 Janson CG, McPhee SW, Leone P, Freese A, During MJ. Viral-based gene transfer to the mammalian CNS for functional genomic studies. Trends Neurosci. 24, 706-712 (2001); 6 Blomer U, Naldini L, Kafri T, Trono D, Verma IM, Gage FH. Highly efficient an sustained gene transfer in adult neurons with a lentivirus vector. J. Virol. 71, 6641-6649 (1997); 7 Costantini LC, Bakowska, JC, Breakefield XO, Isacson O. Gene therapy in the CNS. Gene Ther. 7, 93-109 (2000); 8 Mountain A. Gene therapy: the first decade. Trends Biotechnol. 18, 119-128 (2000; 9 Ozawa CR, Ho JJ, Tsai DJ, Ho DY, Sapolsky RM. Neuroprotective potential of a viral vector system induced by a neurological insult. Proc. Natl Acad. Sci. USA 97, 9270-9275 (2000); 10 Ho DY, McLaughlin JR, Sapolsky RM. Inducible gene expression from defective herpes simplex virus vectors using the tetracycline-responsive promoter system. Mol. Brain Res. 41, 200-209 (1996); 11 Fotaki ME, Pink JR, Mous J. Tetracycline-responsive gene expression in mouse brain after amplicon-mediated gene transfer Gene Ther. 4, 901-908 (1997); 12 Haberman RP, Samulski RJ, McCown TJ. Attenuation of seizures and neuronal death by adeno-associated virus vector galanin expression and secretion. Nat. Med. 9, 1076-1080 (2003); 13 Goverdhana S, Puntel M, Xiong W et al. Regulatable gene expression systems for gene therapy applications: progress and future challenges. Mol. Ther. 12(2), 189-211 (2005); 14 Haberman R, Criswell H, Snowdy S et al. Therapeutic liabilities of in vivo viral vector tropism: adeno-associated virus vectors, NMDAR1 antisense, and focal seizure sensitivity. Mol. Ther. 6, 495-500 (2002); 15 Hommel JD, Sears RM, Georgescu D, Simmons DL, Di Leone RJ. Local gene knockdown in the brain using viral-mediated RNA interference. Nat. Med. 9, 1539-1544 (2003); 16 Fu H, Muenzer J, Samulski RJ et al. Self-complementary adeno-associated virus serotype 2 vector: global distribution andbroad dispersion of AAV-mediated transgene expression in mouse brain. Mol. Ther. 8, 911-917 (2003); 17 Halbert CL, Miller AD, McNamara S et al. Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types 2,5, and 6 in cystic fibrosis and normal populations: implications for gene therapy using AAV vectors. Human Gene Ther. 17, 440-447 (2006); 18 Kaplitt MG, Feigin A, Tang C et al. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, Phase I trial. Lancet 369, 2097-2105 (2007); 19 Y{\'a}{\~n}ez-Mu{\~n}oz RJ, Balaggan KS, MacNeil A. Effective gene therapy with nonintegrating lentiviral vectors. Nat. Med. 12(3), 348-353 (2006); 20 McCarty DM, Young SM Jr, Samulski RJ. Integration of adeno-associated virus (AAV) and recombinant AAV vectors. Ann. Rev. Genet. 38, 819-845 (2004); 21 Burger C, Gorbatyuk OS, Velardo MJ et al. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol. Ther. 10, 302-317 (2004); 22 Cearley CN, Wolfe JH. Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain. Mol. Ther. 13, 528-537 (2006); 23 Boison D. Adenosine-based cell therapy approaches for pharmacoresistant epilepsies. Neurodegener. Dis. 4, 28-33 (2007); 24 Thompson K, Anantharam V, Behrstock S et al. Conditionally immortalized cell lines, engineered to produce and release GABA, modulate the development of behavioral seizures. Exp. Neurol. 161, 481-489 (2000); 25 Gernert M, Thompson KW, Loscher et al. Genetically engineered GABA-producing cells demonstrate anticonvulsant effects and long-term transgene expression when transplanted into the central piriform cortex of rats. Exp. Neurol. 176, 183-192 (2002); 26 Thompson KW, Suchomelova LM. Transplants of cells engineered to produce GABA suppress spontaneous seizures. Epilepsia 45, 4-12 (2004); 27 Richichi C, Lin EJ, Stefanin D et al. Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vector neuropeptide Y expression in the rat hippocampus. J. Neurosci. 24, 3051-3059 (2004); 28 Foti S, Haberman RP, Samulski RJ, McCown TJ. Adeno-associated virus-mediated expression and constitutive secretion of NPY or NPY13-36 suppresses seizure activity in vivo . Gene Ther. 14(21), 1534-1536 (2007); 29 Noe'F, During MJ, Vezzani A. Gene therapy for epilepsy. In: Gene Therapy Of The Central Nervous System: From Bench To Bedside . Kaplitt MG, During MJ (Eds). Academic Press, NY, USA 151-163 (2006); 30 Lin EJ, Richichi C, Young D et al. Recombinant AAV-mediated expression of galanin in rat hippocampus suppresses seizure development. Eur. J. Neurosci. 18, 2087-2092 (2003); 31 McCown TJ. Adeno-associated virus-mediated expression and constitutive secretion of galanin suppresses limbic seizure activity in vivo . Mol. Ther. 14, 63-68 (2006); 32 Raol YH, Lund IV, Bandyopadhyay S et al. Enhancing GABAA receptor 1 subunit levels in hippocampal dentate gyrus inhibits epilepsy development in an animal model of temporal lobe epilepsy. J. Neurosci. 26, 11342-11346 (2006); 33 Roberts DS, Raol Y, Bandyopadhyay S et al. Erg3 stimulation of GABRA4 promoter activity as a mechanism for seizure-induced up-regulation of GABAA receptor 4 subunt expression. Proc. Natl Acad. Sci. USA 102, 11894-11899 (2005); 34 Seki T, Matsubayashi H, Amano T et al. Adenoviral gene transfer of aspartoacylase into the tremor rat, a genetic model of epilepsy, as a trial of gene therapy for inherited epileptic disorders. Neurosci. Lett. 328, 249-252 (2002); 35 Seki T, Matsubayashi H, Amano T et al. Adenoviral gene transfer of aspartoacylase ameliorates tonic convulsions of spontaneously epileptic rats. Neurochem. Int. 45, 171-178 (2004); 36 Noe'F, Nissinen J, Sperk G et al. NPY gene therapy in epileptic rats: inhibition of spontaneous seizures and disease-modifying effects. Epilepsia 48(Suppl. 7), 19-20 (2007); 37 Monahan PE, Samulski RJ. Adeno-associated virus vectors for gene therapy: more pros than cons? Mol. Med. Today 6, 433-440 (2000); 38 Ren G, Li T, Lan, JQ et al. Lentiviral RNAi-induced downregulation of adenosine kinase in human mesenchymal stem cell grafts: a novel perspective for seizure control. Exp. Neurol. 208(1), 26-37 (2007); 39 Freese A, Kaplitt MG, O'Connor WM et al. Direct gene transfer into human epileptogenic hippocampal tissue with an adeno-associated virus vector: implications for a gene therapy approach to epilepsy. Epilepsia 38, 759-766 (1997); 40 Pitkanen A, Sutula TP. Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy. Lancet Neurol. 1, 173-181 (2002); 41 Forsyeth JR. Influence of the immune system on central nervous system gene transfer. In: Gene Therapy Of The Central Nervous System: From Bench To Bedside . Kaplitt MG, During MJ (Eds). Academic Press, NY, USA 45-52 (2006); 42 Vezzani A, Granata T. Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 46, 1724-1743 (2005); 43 Allan SM, Tyrrell PJ, Rothwell NJ. Interleukin-1 and neuronal injury. Nat. Rev. Immunol. 5, 629-640 (2005); 44 Tenenbaum L, Chtarto A, Lehtonen E et al. Recombinant AAV-mediated gene delivery to the central nervous system. J. Gene Med. 6(Suppl. 1) S212-S222 (2004); 45 Lindvall O, Kokaia Z. Stem cells for the treatment of neurological disorders. Nature 441, 1094-1096 (2006); 46 Dumas TC, Sapolsky RM. Gene therapy against neurological insults: sparing neurons versus sparing function. Trends Neurosci. 24, 695-700 (2001); 47 Kudin AP, Debska-Vielhaber G, Vielhaber S, Elger CE, Kunz WS. The mechanism of neuroprotection by topiramate in an animal model of epilepsy. Epilepsia 45, 1478-1487 (2004); 48 Willmore LJ. Antiepileptic drugs and neuroprotection: current status and future roles. Epilepsy Behav. 7(Suppl. 3), S25-S28 (2005); 49 Huber A, Padrun V, Deglon N, Aebischer P, Mohler H, Boison D. Grafts of adenosine-releasing cells suppress seizures in kindling epilepsy. Proc. Natl Acad. Sci. USA 98, 7611-7616 (2001); 101 Office of Biotechnology Activities, National Institutes of Health www4.od.nih.gov/oba/Rdna.htm; 102 Gene Transfer Protocol Report: hippocampal NPY gene transfer in subjects with intractable mesial temporal lobe epilepsy www.gemcris.od.nih.gov/Contents/GC_CLIN_TRIAL_RPT_VIEW.asp?WIN_TYPE=P&CTID=670},
	Number = {12},
	Pages = {1685-92},
	Title = {The promise of gene therapy for the treatment of epilepsy},
	Url = {http://search.proquest.com/docview/889793399?accountid=45097},
	Volume = {7},
	Year = {2007},
	Bdsk-Url-1 = {http://search.proquest.com/docview/889793399?accountid=45097}}

@article{Brainbridge,
	Abstract = {The eye has unique advantages as a target organ for gene therapy of both inherited and acquired ocular disorders and offers a valuable model system for gene therapy. The eye is readily accessible to phenotypic examination and investigation of therapeutic effects in vivo by fundus imaging and electrophysiological techniques. Considerable progress has been made in the development of gene replacement therapies for retinal degenerations resulting from gene defects in photoreceptor cells (rds, RPGRIP, RS-1) and in retinal pigment epithelial cells (MerTK, RPE65, OA1) using recombinant adeno-associated virus and lentivirus-based vectors. Gene therapy also offers a potentially powerful approach to the treatment of complex acquired disorders such as those involving angiogenesis, inflammation and degeneration, by the targeted sustained intraocular delivery of therapeutic proteins. Proposals for clinical trials of gene therapy for early-onset retinal degeneration owing to defects in the gene encoding the visual cycle protein RPE65 have recently received ethical approval.},
	Author = {Bainbridge,J. W. B. and Tan,M. H. and Ali,R. R.},
	Isbn = {09697128},
	Journal = {Gene therapy},
	Keywords = {Biology--Genetics; Gene therapy; Eyes & eyesight; Proteins; Retina -- metabolism; Genetic Vectors -- administration & dosage; Eye Diseases -- metabolism; Gene Transfer Techniques; Genetic Engineering; Humans; Dependovirus -- genetics; Clinical Trials as Topic; Genetic Therapy -- methods; Gene Expression Regulation; Genetic Therapy -- trends; Eye Diseases -- therapy},
	Language = {English},
	Month = {08},
	Note = {Copyright - Copyright Nature Publishing Group Aug 2006; {\'U}ltima actualizaci{\'o}n - 2014-04-30},
	Number = {16},
	Pages = {1191-7},
	Title = {Gene therapy progress and prospects: the eye},
	Url = {http://search.proquest.com/docview/218711320?accountid=45097},
	Volume = {13},
	Year = {2006},
	Bdsk-Url-1 = {http://search.proquest.com/docview/218711320?accountid=45097}}

@article{Reinhart,
	Abstract = {Tissue engineering is an interdisciplinary field that applies the principles of engineering and life sciences toward the development of biological substitutes that restore, maintain or improve tissue function. It is hoped that forming tissue de novo will overcome many problems in plastic surgery associated with such areas as wound healing and the immunogenicity of transplanted tissue that lead to dysfunctional repair. Gene therapy is the science of the transfer of genetic material into individuals for therapeutic purposes by altering cellular function or structure at the molecular level. Recently, tissue engineering has been used in conjunction with gene therapy as a hybrid approach. This combination of stem-cell-based tissue engineering with gene therapy has the potential to provide regenerative tissue cells within an environment of optimal regulatory protein expression and would have many benefits in various areas such as the transplantation of skin, cartilage or bone. The aim of this review is to outline tissue engineering and possible applications of gene therapy in the field of biomedical engineering as well as basic principles of gene therapy, vectors and gene delivery. Copyright {\copyright} 2006 S. Karger AG, Basel},
	Author = {Ulrich,Reinhart G. and Riedel,Katrin and H{\"o}rmann,Karl and Riedel,Frank},
	Isbn = {14226405},
	Journal = {Cells Tissues Organs},
	Keywords = {Biology; Animals; Extracellular Matrix -- metabolism; Gene Transfer Techniques; Cartilage -- metabolism; Wound Healing; Humans; Surgery, Plastic -- methods; Models, Biological; Chondrocytes -- metabolism; Bone & Bones -- metabolism; Biomedical Engineering -- methods; Mesenchymal Stromal Cells -- cytology; Stem Cells -- cytology; Genetic Therapy -- methods; Tissue Engineering -- methods},
	Language = {English},
	Month = {12},
	Note = {Copyright - Copyright (c) 2006 S. Karger AG, Basel; {\'U}ltima actualizaci{\'o}n - 2014-03-28},
	Number = {4},
	Pages = {169-79},
	Title = {Perspectives of Gene Therapy in Stem Cell Tissue Engineering},
	Url = {http://search.proquest.com/docview/222637852?accountid=45097},
	Volume = {183},
	Year = {2006},
	Bdsk-Url-1 = {http://search.proquest.com/docview/222637852?accountid=45097}}

@article{Spink,
	Abstract = {The concept and application of ethical principles in the context of medical research is changing rapidly. This is especially true for fast moving fields such as gene therapy, a relatively new but rapidly maturing field offering opportunities to influence health at a fundamental level, which may become a cornerstone of medicine. By 2004, over 700 gene therapy clinical protocols had been initiated worldwide, and two highly publicized gene therapy-related side effects have helped to shape recent ethical debate. These events have influenced not only clinical trial design but also public opinion and systems of independent oversight. Both the science of gene therapy and the regulatory environment are continually evolving. How well the field is able to respond to these challenges will determine the extent to which gene therapy will ultimately be integrated into medical practice.},
	Author = {Spink,J. and Geddes,D.},
	Isbn = {09697128},
	Journal = {Gene therapy},
	Keywords = {Biology--Genetics; Genetic Therapy -- ethics; Clinical Medicine -- trends; Animals; Humans; Safety; Ethics, Medical; Forecasting; Research Design; Genetic Therapy -- trends},
	Language = {English},
	Month = {11},
	Note = {Copyright - Copyright Nature Publishing Group Nov 2004; {\'U}ltima actualizaci{\'o}n - 2014-04-30},
	Number = {22},
	Pages = {1611-6},
	Title = {Gene Therapy Progress and Prospects: Bringing gene therapy into medical practice: the evolution of international ethics and the regulatory environment},
	Url = {http://search.proquest.com/docview/218702534?accountid=45097},
	Volume = {11},
	Year = {2004},
	Bdsk-Url-1 = {http://search.proquest.com/docview/218702534?accountid=45097}}

@article{PMID:22043080,
	Author = {Ormandy, EH and Dale, J and Griffin, G},
	Issn = {0008-5286},
	Journal = {The Canadian veterinary journal. La revue veterinaire canadienne},
	Month = {May},
	Number = {5},
	Pages = {544---550},
	Title = {Genetic engineering of animals: ethical issues, including welfare concerns},
	Url = {http://europepmc.org/abstract/MED/22043080},
	Volume = {52},
	Year = {2011},
	Bdsk-Url-1 = {http://europepmc.org/abstract/MED/22043080}}

@article{PNS:803840,
	Author = {Rowland,I. R.},
	Doi = {10.1079/PNS2001135},
	Issn = {1475-2719},
	Issue = {01},
	Journal = {Proceedings of the Nutrition Society},
	Month = {2},
	Numpages = {5},
	Pages = {25--29},
	Title = {Genetically modified foods, science, consumers and the media},
	Url = {http://journals.cambridge.org/article_S002966510200006X},
	Volume = {61},
	Year = {2002},
	Bdsk-Url-1 = {http://journals.cambridge.org/article_S002966510200006X},
	Bdsk-Url-2 = {http://dx.doi.org/10.1079/PNS2001135}}

@article{JGM:JGM604,
	Author = {Elmadbouh, Ibrahim and Rossignol, Patrick and Meilhac, Olivier and Vranckx, Roger and Pichon, Chantal and Pouzet, Bruno and Midoux, Patrick and Michel, Jean-Baptiste},
	Doi = {10.1002/jgm.604},
	Issn = {1521-2254},
	Journal = {The Journal of Gene Medicine},
	Keywords = {cell therapy, gene therapy, myocardial infarction, cationic vectors, secreted alkaline phosphatase, zinc chloride},
	Number = {10},
	Pages = {1112--1124},
	Publisher = {John Wiley & Sons, Ltd.},
	Title = {Optimization of in vitro vascular cell transfection with non-viral vectors for in vivo applications},
	Url = {http://dx.doi.org/10.1002/jgm.604},
	Volume = {6},
	Year = {2004},
	Bdsk-Url-1 = {http://dx.doi.org/10.1002/jgm.604}}

@article{10.1172/JCI116874,
	Abstract = {Glomerulosclerosis, a final common lesion of various glomerular diseases, is characterized by mesangial cell proliferation and extracellular matrix (ECM) expansion. TGF-beta and PDGF are known to play a critical role in the regulation of ECM metabolism and mesenchymal cell proliferation, respectively. However, there is little evidence to demonstrate the direct role of each of these growth factors in the pathogenesis of glomerulosclerosis. Using an in vivo transfection technique, we could realize the selective overexpression of single growth factor in the kidney. The introduction of either TGF-beta or PDGF-B gene alone into the kidney induced glomerulosclerosis, although the patterns of action of these growth factors were different; TGF-beta affected ECM accumulation rather than cell proliferation and PDGF affected the latter rather than the former.},
	Author = {Y Isaka AND Y Fujiwara AND N Ueda AND Y Kaneda AND T Kamada AND E Imai},
	Doi = {10.1172/JCI116874},
	Journal = {The Journal of Clinical Investigation},
	Month = {12},
	Number = {6},
	Pages = {2597-2601},
	Publisher = {The American Society for Clinical Investigation},
	Title = {Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney.},
	Url = {http://www.jci.org/articles/view/116874},
	Volume = {92},
	Year = {1993},
	Bdsk-Url-1 = {http://www.jci.org/articles/view/116874},
	Bdsk-Url-2 = {http://dx.doi.org/10.1172/JCI116874}}

@article{Felgner01111987,
	Abstract = {A DNA-transfection protocol has been developed that makes use of a synthetic cationic lipid, N-[1-(2,3-dioleyloxy)propyl]-N,N,N-trimethylammonium chloride (DOTMA). Small unilamellar liposomes containing DOTMA interact spontaneously with DNA to form lipid-DNA complexes with 100% entrapment of the DNA, DOTMA facilitates fusion of the complex with the plasma membrane of tissue culture cells, resulting in both uptake and expression of the DNA. The technique is simple, highly reproducible, and effective for both transient and stable expression of transfected DNA. Depending upon the cell line, lipofection is from 5- to greater than 100-fold more effective than either the calcium phosphate or the DEAE-dextran transfection technique.},
	Author = {Felgner, P L and Gadek, T R and Holm, M and Roman, R and Chan, H W and Wenz, M and Northrop, J P and Ringold, G M and Danielsen, M},
	Eprint = {http://www.pnas.org/content/84/21/7413.full.pdf+html},
	Journal = {Proceedings of the National Academy of Sciences},
	Number = {21},
	Pages = {7413-7417},
	Title = {Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure},
	Url = {http://www.pnas.org/content/84/21/7413.abstract},
	Volume = {84},
	Year = {1987},
	Bdsk-Url-1 = {http://www.pnas.org/content/84/21/7413.abstract}}

@article{TaeKyung,
	Author = {Kim, TaeKyung and Eberwine, JamesH.},
	Doi = {10.1007/s00216-010-3821-6},
	Issn = {1618-2642},
	Journal = {Analytical and Bioanalytical Chemistry},
	Keywords = {Transfection; Nucleic acid; Gene; Single cell},
	Language = {English},
	Number = {8},
	Pages = {3173-3178},
	Publisher = {Springer-Verlag},
	Title = {Mammalian cell transfection: the present and the future},
	Url = {http://dx.doi.org/10.1007/s00216-010-3821-6},
	Volume = {397},
	Year = {2010},
	Bdsk-Url-1 = {http://dx.doi.org/10.1007/s00216-010-3821-6}}

@article{Verhoog2003294,
	Author = {Henk Verhoog},
	Doi = {http://dx.doi.org/10.1016/S0167-7799(03)00142-2},
	Issn = {0167-7799},
	Journal = {Trends in Biotechnology},
	Number = {7},
	Pages = {294 - 297},
	Title = {Naturalness and the genetic modification of animals},
	Url = {http://www.sciencedirect.com/science/article/pii/S0167779903001422},
	Volume = {21},
	Year = {2003},
	Bdsk-Url-1 = {http://www.sciencedirect.com/science/article/pii/S0167779903001422},
	Bdsk-Url-2 = {http://dx.doi.org/10.1016/S0167-7799(03)00142-2}}

@article{Seung,
	Abstract = {Advances in gene-based medicine since 1990s have ushered in new therapeutic strategy of gene therapy for inborn error genetic diseases and cancer. Malignant brain tumors such as glioblastoma multiforme and medulloblastoma remain virtually untreatable and lethal. Currently available treatment for brain tumors including radical surgical resection followed by radiation and chemotherapy, have substantially improved the survival rate in patients suffering from these brain tumors; however, it remains incurable in large proportion of patients. Therefore, there is substantial need for effective, low-toxicity therapies for patients with malignant brain tumors, and gene therapy targeting brain tumors should fulfill this requirement. Gene therapy for brain tumors includes many therapeutic strategies and these strategies can be grouped in two major categories: molecular and immunologic. The widely used molecular gene therapy approach is suicide gene therapy based on the conversion of non-toxic prodrugs into active anticancer agents via introduction of enzymes and genetic immunotherapy involves the gene transfer of immune-stimulating cytokines including IL-4, IL-12 and TRAIL. For both molecular and immune gene therapy, neural stem cells (NSCs) can be used as delivery vehicle of therapeutic genes. NSCs possess an inherent tumor tropism that supports their use as a reliable delivery vehicle to target therapeutic gene products to primary brain tumors and metastatic cancers throughout the brain. Significance of the NSC-based gene therapy for brain tumor is that it is possible to exploit the tumor-tropic property of NSCs to mediate effective, tumor-selective therapy for primary and metastatic cancers in the brain and outside, for which no tolerated curative treatments are currently available.PUBLICATION ABSTRACT]},
	Author = {Kim,Seung U.},
	Isbn = {15508943},
	Journal = {Stem Cell Reviews},
	Keywords = {Biology--Genetics; Animals; Genes, Transgenic, Suicide; Gene Transfer Techniques; Brain Neoplasms -- immunology; Humans; Clinical Trials as Topic; Brain Neoplasms -- therapy; Brain Neoplasms -- genetics; Neural Stem Cells -- metabolism; Genetic Therapy -- methods},
	Language = {English},
	Month = {03},
	Note = {Copyright - Springer Science+Business Media, LLC 2011; {\'U}ltima actualizaci{\'o}n - 2014-04-02},
	Number = {1},
	Pages = {130-40},
	Title = {Neural Stem Cell-based Gene Therapy for Brain Tumors},
	Url = {http://search.proquest.com/docview/856961513?accountid=45097},
	Volume = {7},
	Year = {2011},
	Bdsk-Url-1 = {http://search.proquest.com/docview/856961513?accountid=45097}}

@article{Cooley,
	Abstract = {In one study funded by the United States Department of Agriculture, people from North Dakota were interviewed to discover which moral principles they use in evaluating the morality of transgenic organisms and their introduction into markets. It was found that although the moral codes the human subjects employed were very similar, their views on transgenics were vastly different. In this paper, the codes that were used by the respondents are developed, compared to that of the academically composed Belmont Report, and then modified to create the more practical Common Moral Code. At the end, it is shown that the Common Moral Code has inherent inconsistency flaws that might be resolvable, but would require extensive work on the definition of terms and principles. However, the effort is worthwhile, especially if it results in a common moral code that all those involved in the debate are willing to use in negotiating a resolution to their differences. PUBLICATION ABSTRACT]},
	Author = {Cooley,D. R. and Goreham,Gary and Youngs,George A.},
	Isbn = {11877863},
	Journal = {Journal of Agricultural and Environmental Ethics},
	Keywords = {Philosophy; Morality; Studies; Transgenic animals; Bioethics; Attitudes; United States; US; 8400:Agriculture industry; 9130:Experimental/theoretical; 9190:United States},
	Language = {English},
	Note = {Copyright - Copyright (c) 2004 Kluwer Academic Publishers; Caracter{\'\i}sticas del documento - references; {\'U}ltima actualizaci{\'o}n - 2010-06-06; SubjectsTermNotLitGenreText - United States; US},
	Number = {6},
	Pages = {517-544},
	Title = {Practical Moral Codes In the Transgenic Organism Debate},
	Url = {http://search.proquest.com/docview/196571412?accountid=45097},
	Volume = {17},
	Year = {2004},
	Bdsk-Url-1 = {http://search.proquest.com/docview/196571412?accountid=45097}}

@article{Iredale,
	Abstract = {Objective: This study aimed to explore some factors influencing perceptions of human gene therapy. Method: A small qualitative study using two semi-structured interviews per participant (n = 22). The groups comprised (1) people with cystic fibrosis and members of their family (n = 9), and (2) students from a science evening class as well as lay members of the public selected from the practice list of a local general practitioner (n = 13). Results: This pilot study demonstrates support for somatic gene therapy and ambivalence about germline gene therapy. A clear distinction is drawn between therapy and enhancement, with the majority opposing gene enhancement. Conclusions: Attitudes towards the acceptability of gene therapy are not necessarily determined by experience of, or exposure to, a genetic condition. More research is needed with the general public to determine what is perceived to be acceptable public policy in this field. Copyright {\copyright} 2003 S. Karger AG, Basel},
	Author = {Iredale,Rachel and Dolan,Gina and McDonald,Kevin and Kirk,Maggie},
	Isbn = {14222795},
	Journal = {Community Genetics},
	Keywords = {Biology--Genetics; Qualitative Research; Questionnaires; Humans; Adult; Pilot Projects; Middle Aged; Wales; Adolescent; Public Opinion; Male; Female; Gene Therapy -- psychology; Attitude to Health},
	Language = {English},
	Note = {Copyright - Copyright (c) 2003 S. Karger AG, Basel; {\'U}ltima actualizaci{\'o}n - 2012-02-09},
	Number = {3},
	Pages = {139-46},
	Title = {Public Attitudes to Human Gene Therapy: A Pilot Study in Wales},
	Url = {http://search.proquest.com/docview/223133094?accountid=45097},
	Volume = {6},
	Year = {2003},
	Bdsk-Url-1 = {http://search.proquest.com/docview/223133094?accountid=45097}}

@article{Durocher15012002,
	Abstract = {A scalable transfection procedure using polyethylenimine (PEI) is described for the human embryonic kidney 293 cell line grown in suspension. Green fluorescent protein (GFP) and human placental secreted alkaline phosphatase (SEAP) were used as reporter genes to monitor transfection efficiency and productivity. Up to 75% of GFP-positive cells were obtained using linear or branched 25 kDa PEI. The 293 cell line and two genetic variants, either expressing the SV40 large T-antigen (293T) or the Epstein--Barr virus (EBV) EBNA1 protein (293E), were tested for protein expression. The highest expression level was obtained with 293E cells using the EBV oriP-containing plasmid pCEP4. We designed the pTT vector, an oriP-based vector having an improved cytomegalovirus expression cassette. Using this vector, 10- and 3-fold increases in SEAP expression was obtained in 293E cells compared with pcDNA3.1 and pCEP4 vectors, respectively. The presence of serum had a positive effect on gene transfer and expression. Transfection of suspension-growing cells was more efficient with linear PEI and was not affected by the presence of medium conditioned for 24 h. Using the pTT vector, >20 mg/l of purified His-tagged SEAP was recovered from a 3.5 l bioreactor. Intracellular proteins were also produced at levels as high as 50 mg/l, representing up to 20% of total cell proteins.},
	Author = {Durocher, Yves and Perret, Sylvie and Kamen, Amine},
	Doi = {10.1093/nar/30.2.e9},
	Eprint = {http://nar.oxfordjournals.org/content/30/2/e9.full.pdf+html},
	Journal = {Nucleic Acids Research},
	Number = {2},
	Pages = {e9},
	Title = {High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells},
	Url = {http://nar.oxfordjournals.org/content/30/2/e9.abstract},
	Volume = {30},
	Year = {2002},
	Bdsk-Url-1 = {http://nar.oxfordjournals.org/content/30/2/e9.abstract},
	Bdsk-Url-2 = {http://dx.doi.org/10.1093/nar/30.2.e9}}

@article{Slowing20081278,
	Author = {Igor I. Slowing and Juan L. Vivero-Escoto and Chia-Wen Wu and Victor S.-Y. Lin},
	Doi = {http://dx.doi.org/10.1016/j.addr.2008.03.012},
	Issn = {0169-409X},
	Journal = {Advanced Drug Delivery Reviews},
	Keywords = {Biocompatibility},
	Note = {Inorganic Nanoparticles in Drug Delivery},
	Number = {11},
	Pages = {1278 - 1288},
	Title = {Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers},
	Url = {http://www.sciencedirect.com/science/article/pii/S0169409X08000951},
	Volume = {60},
	Year = {2008},
	Bdsk-Url-1 = {http://www.sciencedirect.com/science/article/pii/S0169409X08000951},
	Bdsk-Url-2 = {http://dx.doi.org/10.1016/j.addr.2008.03.012}}

@article{Prabha2002105,
	Author = {Swayam Prabha and Wen-Zhong Zhou and Jayanth Panyam and Vinod Labhasetwar},
	Doi = {http://dx.doi.org/10.1016/S0378-5173(02)00315-0},
	Issn = {0378-5173},
	Journal = {International Journal of Pharmaceutics},
	Keywords = {Cellular uptake},
	Number = {1--2},
	Pages = {105 - 115},
	Title = {Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles},
	Url = {http://www.sciencedirect.com/science/article/pii/S0378517302003150},
	Volume = {244},
	Year = {2002},
	Bdsk-Url-1 = {http://www.sciencedirect.com/science/article/pii/S0378517302003150},
	Bdsk-Url-2 = {http://dx.doi.org/10.1016/S0378-5173(02)00315-0}}

@article{strulovicihuman2007,
	Author = {Yael Strulovici and Philip L Leopold and Timothy P O'Connor and Robert G Pergolizzi and Ronald G Crystal},
	Doi = {10.1038/mt.sj.6300125},
	Journal = {Molecular Therapy},
	Number = {5},
	Pages = {850-866},
	Title = {Human Embryonic Stem Cells and Gene Therapy},
	Url = {http://dx.doi.org/10.1038/mt.sj.6300125},
	Volume = {15},
	Year = {2007},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/mt.sj.6300125}}

@article{PMID:10625387,
	Author = {Luo, D and Saltzman, WM},
	Doi = {10.1038/71889},
	Issn = {1087-0156},
	Journal = {Nature biotechnology},
	Month = {January},
	Number = {1},
	Pages = {33---37},
	Title = {Synthetic DNA delivery systems},
	Url = {http://europepmc.org/abstract/MED/10625387},
	Volume = {18},
	Year = {2000},
	Bdsk-Url-1 = {http://europepmc.org/abstract/MED/10625387},
	Bdsk-Url-2 = {http://dx.doi.org/10.1038/71889}}

@article{bonettathe2005,
	Author = {Laura Bonetta},
	Doi = {10.1038/nmeth1105-875},
	Journal = {Nature Methods},
	Number = {11},
	Pages = {875-883},
	Title = {The inside scoop---evaluating gene delivery methods},
	Url = {http://dx.doi.org/10.1038/nmeth1105-875},
	Volume = {2},
	Year = {2005},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/nmeth1105-875}}

@article{Eghbali01121991,
	Abstract = {Gap junction channels provide a pathway for exchange of ions and small molecules between coupled cells, and this exchange is believed to be critical for normal tissue growth and development. As a test for a role of gap junction-mediated intercellular communication in control of cell growth, we have compared growth rates of communication-deficient human tumor cells (SKHep1) with clones stably transfected with cDNA encoding the rat liver gap junction protein connexin 32. In culture, growth rates for parental and transfected clones were similar. However, when sizes of tumors were evaluated following injection of these clones into athymic nude mice, growth rates for two well-coupled clones were significantly lower than for communication-deficient or poorly coupled clones. This study demonstrates that growth rate of these tumor cells in situ is negatively correlated with strength of intercellular communication.},
	Author = {Eghbali, B and Kessler, J A and Reid, L M and Roy, C and Spray, D C},
	Eprint = {http://www.pnas.org/content/88/23/10701.full.pdf+html},
	Journal = {Proceedings of the National Academy of Sciences},
	Number = {23},
	Pages = {10701-10705},
	Title = {Involvement of gap junctions in tumorigenesis: transfection of tumor cells with connexin 32 cDNA retards growth in vivo},
	Url = {http://www.pnas.org/content/88/23/10701.abstract},
	Volume = {88},
	Year = {1991},
	Bdsk-Url-1 = {http://www.pnas.org/content/88/23/10701.abstract}}

@article{Liu,
	Author = {Liu, Chaoting and Dalby, Brian and Chen, Weixing and Kilzer, JenniferM. and Chiou, HenryC.},
	Doi = {10.1007/s12033-008-9051-x},
	Issn = {1073-6085},
	Journal = {Molecular Biotechnology},
	Keywords = {Transient transfection; Suspension culture; HEK-293; CHO; Transfection efficiency; Protein production},
	Language = {English},
	Number = {2},
	Pages = {141-153},
	Publisher = {Humana Press Inc},
	Title = {Transient Transfection Factors for High-Level Recombinant Protein Production in Suspension Cultured Mammalian Cells},
	Url = {http://dx.doi.org/10.1007/s12033-008-9051-x},
	Volume = {39},
	Year = {2008},
	Bdsk-Url-1 = {http://dx.doi.org/10.1007/s12033-008-9051-x}}

@article{branskigene2006,
	Author = {L K Branski and C T Pereira and D N Herndon and M G Jeschke},
	Doi = {10.1038/sj.gt.3302837},
	Journal = {Gene Therapy},
	Number = {1},
	Pages = {1-10},
	Title = {Gene therapy in wound healing: present status and future directions},
	Url = {http://dx.doi.org/10.1038/sj.gt.3302837},
	Volume = {14},
	Year = {2006},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/sj.gt.3302837}}

@article{Devlin22062004,
	Abstract = {Environmental risk assessment of genetically modified organisms requires determination of their fitness and invasiveness relative to conspecifics and other ecosystem members. Cultured growth hormone transgenic coho salmon (Oncorhynchus kisutch) have enhanced feeding capacity and growth, which can result in large enhancements in body size (>7-fold) relative to nontransgenic salmon, but in nature, the ability to compete for available food is a key factor determining survival fitness and invasiveness of a genotype. When transgenic and nontransgenic salmon were cohabitated and competed for different levels of food, transgenic salmon consistently outgrew nontransgenic fish and could affect the growth of nontransgenic cohorts except when food availability was high. When food abundance was low, dominant individuals emerged, invariably transgenic, that directed strong agonistic and cannibalistic behavior to cohorts and dominated the acquisition of limited food resources. When food availability was low, all groups containing transgenic salmon experienced population crashes or complete extinctions, whereas groups containing only nontransgenic salmon had good (72.0 $\pm$ 4.3% SE) survival, and their population biomass continued to increase. Thus, effects of growth hormone transgenic salmon on experimental populations were primarily mediated by an interaction between food availability and population structure. These data, while indicative of forces which may act on natural populations, also underscore the importance of genotype by environment interactions in influencing risk assessment data for genetically modified organisms and suggest that, for species such as salmon which are derived from large complex ecosystems, considerable caution is warranted in applying data from individual studies.},
	Author = {Devlin, Robert H. and D'Andrade, Mark and Uh, Mitchell and Biagi, Carlo A.},
	Doi = {10.1073/pnas.0400023101},
	Eprint = {http://www.pnas.org/content/101/25/9303.full.pdf+html},
	Journal = {Proceedings of the National Academy of Sciences of the United States of America},
	Number = {25},
	Pages = {9303-9308},
	Title = {Population effects of growth hormone transgenic coho salmon depend on food availability and genotype by environment interactions},
	Url = {http://www.pnas.org/content/101/25/9303.abstract},
	Volume = {101},
	Year = {2004},
	Bdsk-Url-1 = {http://www.pnas.org/content/101/25/9303.abstract},
	Bdsk-Url-2 = {http://dx.doi.org/10.1073/pnas.0400023101}}

@article{ripps1995transgenic,
	Author = {Ripps, Michael E and Huntley, George W and Hof, Patrick R and Morrison, John H and Gordon, Jon W},
	Journal = {Proceedings of the National Academy of Sciences},
	Number = {3},
	Pages = {689--693},
	Publisher = {National Acad Sciences},
	Title = {Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis},
	Volume = {92},
	Year = {1995}}

@article{houdebine2009production,
	Author = {Houdebine, Louis-Marie},
	Journal = {Comparative immunology, microbiology and infectious diseases},
	Number = {2},
	Pages = {107--121},
	Publisher = {Elsevier},
	Title = {Production of pharmaceutical proteins by transgenic animals},
	Volume = {32},
	Year = {2009}}

@article{berkowitz1994transgenic,
	Author = {Berkowitz, David B and Kryspin-S{\o}rensen, Ilona},
	Journal = {Nature Biotechnology},
	Number = {3},
	Pages = {247--252},
	Publisher = {Nature Publishing Group},
	Title = {Transgenic fish: Safe to eat?},
	Volume = {12},
	Year = {1994}}

@article{berkowitz1993food,
	Author = {Berkowitz, DB},
	Journal = {Journal of animal science},
	Number = {suppl 3},
	Pages = {43--46},
	Publisher = {American Society of Animal Science},
	Title = {The food safety of transgenic animals: implications from traditional breeding.},
	Volume = {71},
	Year = {1993}}

@article{yanni2004laboratory,
	Author = {Yanni, Amalia E},
	Journal = {Laboratory animals},
	Number = {3},
	Pages = {246--256},
	Publisher = {SAGE Publications},
	Title = {The laboratory rabbit: an animal model of atherosclerosis research},
	Volume = {38},
	Year = {2004}}

@article{yom1993genetic,
	Author = {Yom, Heng-Cherl and Bremel, Robert D},
	Journal = {The American journal of clinical nutrition},
	Number = {2},
	Pages = {299S--306S},
	Publisher = {Am Soc Nutrition},
	Title = {Genetic engineering of milk composition: modification of milk components in lactating transgenic animals.},
	Volume = {58},
	Year = {1993}}

@article{pintado1998transgenesis,
	Author = {Pintado, B and Guti{\'e}rrez-Ad{\'a}n, A},
	Journal = {Reproduction, nutrition, development},
	Number = {5-6},
	Pages = {535--544},
	Title = {Transgenesis in large domestic species: future development for milk modification.},
	Volume = {39},
	Year = {1998}}

@article{Sundstrom06032007,
	Abstract = {Production of transgenic animals has raised concern regarding their potential ecological impact should they escape or be released to the natural environment. This concern has arisen mainly from research on laboratory-reared animals and theoretical modeling exercises. In this study, we used biocontained naturalized stream environments and conventional hatchery environments to show that differences in phenotype between transgenic and wild genotypes depend on rearing conditions and, critically, that such genotype-by-environment interactions may influence subsequent ecological effects in nature. Genetically wild and growth hormone transgenic coho salmon (Oncorhynchus kisutch) were reared from the fry stage under either standard hatchery conditions or under naturalized stream conditions. When reared under standard hatchery conditions, the transgenic fish grew almost three times longer than wild conspecifics and had (under simulated natural conditions) stronger predation effects on prey than wild genotypes (even after compensation for size differences). In contrast, when fish were reared under naturalized stream conditions, transgenic fish were only 20% longer than the wild fish, and the magnitude of difference in relative predation effects was much reduced. These data show that genotype-by-environment interactions can influence the relative phenotype of transgenic and wild-type organisms and that extrapolations of ecological consequences from phenotypes developed in the unnatural laboratory environment may lead to an overestimation or underestimation of ecological risk. Thus, for transgenic organisms that may not be released to nature, the establishment of a range of highly naturalized environments will be critical for acquiring reliable experimental data to be used in risk assessments.},
	Author = {Sundstr{\"o}m, L. F. and L{\~o}hmus, M. and Tymchuk, W. E. and Devlin, Robert H.},
	Doi = {10.1073/pnas.0608767104},
	Eprint = {http://www.pnas.org/content/104/10/3889.full.pdf+html},
	Journal = {Proceedings of the National Academy of Sciences},
	Number = {10},
	Pages = {3889-3894},
	Title = {Gene--environment interactions influence ecological consequences of transgenic animals},
	Url = {http://www.pnas.org/content/104/10/3889.abstract},
	Volume = {104},
	Year = {2007},
	Bdsk-Url-1 = {http://www.pnas.org/content/104/10/3889.abstract},
	Bdsk-Url-2 = {http://dx.doi.org/10.1073/pnas.0608767104}}

@article{maga2006consumption,
	Author = {Maga, Elizabeth A and Walker, Richard L and Anderson, Gary B and Murray, James D},
	Journal = {Transgenic research},
	Number = {4},
	Pages = {515--519},
	Publisher = {Springer},
	Title = {Consumption of milk from transgenic goats expressing human lysozyme in the mammary gland results in the modulation of intestinal microflora},
	Volume = {15},
	Year = {2006}}

@article{anthe2002,
	Author = {Maja Buc{\'a}n and Ted Abel},
	Doi = {10.1038/nrg728},
	Journal = {Nature Reviews Genetics},
	Number = {2},
	Pages = {114-123},
	Title = {The mouse: genetics meets behaviour},
	Url = {http://dx.doi.org/10.1038/nrg728},
	Volume = {3},
	Year = {2002},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/nrg728}}

@article{miller2008fda,
	Author = {Miller, Henry I},
	Journal = {Nature biotechnology},
	Number = {2},
	Pages = {159--160},
	Publisher = {Nature Publishing Group},
	Title = {FDA on transgenic animals---a dog's breakfast?},
	Volume = {26},
	Year = {2008}}

@article{food2003fda,
	Author = {Food and Drug Administration and others},
	Journal = {Website: http://www. fda. gov/bbs/topics/NEWS/2003/NEW00994. html (accessed on 10 December 2003)},
	Title = {FDA statement regarding glofish, 9 December},
	Year = {2003}}

@article{allison2008industry,
	Author = {Allison, Malorye},
	Journal = {Nature Biotechnology},
	Number = {6},
	Pages = {596--597},
	Publisher = {Nature Publishing Group},
	Title = {Industry welcomes Genetic Information Nondiscrimination Act},
	Volume = {26},
	Year = {2008}}

@article{costantini1981introduction,
	Author = {Costantini, F and Lacy, E},
	Journal = {Nature},
	Number = {5836},
	Pages = {92},
	Title = {Introduction of a rabbit beta-globin gene into the mouse germ line.},
	Volume = {294},
	Year = {1981}}

@article{fox2008fda,
	Author = {Fox, Jeffrey L},
	Journal = {Nature biotechnology},
	Number = {11},
	Pages = {1205--1207},
	Publisher = {Nature Publishing Group},
	Title = {FDA transgenic animal guidance finally surfaces},
	Volume = {26},
	Year = {2008}}

@article{scotto2013primera,
	Author = {Scotto, Carlos and Serna, Fernando},
	Journal = {Scientia Agropecuaria},
	Number = {3},
	Pages = {257--264},
	Title = {Primera identificaci{\'o}n molecular del transgen de la prote{\'\i}na fluorescente roja (RFP) en peces Cebra (\textit{Danio rerio}) transg{\'e}nicos ornamentales introducidos en el Per{\'u}},
	Volume = {4},
	Year = {2013}}

@article{espinoza2012reproduccion,
	Author = {Scotto Espinoza, Carlos},
	Journal = {Scientia Agropecuaria},
	Number = {1},
	Pages = {89--93},
	Publisher = {Facultad de Ciencias Agropecuarias},
	Title = {Reproducci{\'o}n e hibridaci{\'o}n de peces transg{\'e}nicos fluorescentes en cautiverio: un alcance prospectivo},
	Volume = {3},
	Year = {2012}}

@article{gong2003development,
	Author = {Gong, Zhiyuan and Wan, Haiyan and Tay, Tuan Leng and Wang, Hai and Chen, Mingru and Yan, Tie},
	Journal = {Biochemical and biophysical research communications},
	Number = {1},
	Pages = {58--63},
	Publisher = {Elsevier},
	Title = {Development of transgenic fish for ornamental and bioreactor by strong expression of fluorescent proteins in the skeletal muscle},
	Volume = {308},
	Year = {2003}}

@article{sparks2014covert,
	Author = {Sparks, John S and Schelly, Robert C and Smith, W Leo and Davis, Matthew P and Tchernov, Dan and Pieribone, Vincent A and Gruber, David F},
	Journal = {PloS one},
	Number = {1},
	Pages = {e83259},
	Publisher = {Public Library of Science},
	Title = {The Covert World of Fish Biofluorescence: A Phylogenetically Widespread and Phenotypically Variable Phenomenon},
	Volume = {9},
	Year = {2014}}


@misc{avner2012method,
	Author = {Avner, David B and Bocklandt, Sven and Kehler, James},
	Month = jun # {~7},
	Note = {US Patent 20,120,142,110},
	Title = {Method of Genetically Altering and Producing Allergy Free Cats},
	Year = {2012}}

@article{niemann2007transgenic,
	Author = {Niemann, Heiner and Kues, Wilfried A},
	Journal = {Reproduction, Fertility and Development},
	Number = {6},
	Pages = {762--770},
	Publisher = {CSIRO},
	Title = {Transgenic farm animals: an update},
	Volume = {19},
	Year = {2007}}

@article{ledford2013transgenic,
	Author = {Ledford, H},
	Journal = {Nature},
	Number = {7447},
	Pages = {17--18},
	Title = {Transgenic salmon nears approval.},
	Volume = {497},
	Year = {2013}}

@incollection{Schenborn,
	Author = {Schenborn, ElaineT.},
	Booktitle = {Transcription Factor Protocols},
	Doi = {10.1385/1-59259-686-X:91},
	Editor = {Tymms, MartinJ.},
	Isbn = {978-0-89603-573-7},
	Language = {English},
	Pages = {91-102},
	Publisher = {Humana Press},
	Series = {Methods in Molecular Biology{\texttrademark}},
	Title = {Transfection Technologies},
	Url = {http://dx.doi.org/10.1385/1-59259-686-X%3A91},
	Volume = {130},
	Year = {2000},
	Bdsk-Url-1 = {http://dx.doi.org/10.1385/1-59259-686-X%3A91},
	Bdsk-Url-2 = {http://dx.doi.org/10.1385/1-59259-686-X:91}}

@article{maslow1943theory,
  title={A theory of human motivation.},
  author={Maslow, Abraham Harold},
  journal={Psychological review},
  volume={50},
  number={4},
  pages={370},
  year={1943},
  publisher={American Psychological Association}
}

@article{butt2012hypoallergenic,
  title={Do hypoallergenic cats and dogs exist?},
  author={Butt, Ahmed and Rashid, Daanish and Lockey, Richard F},
  journal={Annals of Allergy, Asthma \& Immunology},
  volume={108},
  number={2},
  pages={74--76},
  year={2012},
  publisher={Elsevier}
}